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ABSTRACT 
 
Jessica Grantham Sparrow: Coping with ADHD: Experiences of Pregnant Women 
(Under the direction of Grace Hubbard) 
 
First-line treatment in the management of attention-deficit hyperactivity disorder 
(ADHD) is stimulant medication; however, there is insufficient data regarding the safe use of 
stimulants during pregnancy. Women with ADHD who become pregnant and were managed pre-
pregnancy with stimulants are generally advised to discontinue this medication. There is limited 
description in the literature of how ADHD manifests during pregnancy, resulting in limited 
guidance to providers for symptom management and best practices in their care of pregnant 
women with ADHD. The aim of this project is to identify influences on the process of coping 
and health-care decision making for women with ADHD during their pregnancy.  A mixed-
methods approach is used, providing qualitative data from two extensive interviews and 
qualitative data from 33 respondents to a Qualtrics™ online survey. The findings were analyzed 
separately and then compared for contrasts and similarities.  
Quantitative and qualitative sources support the importance of multi-contextual factors as 
facilitators for or barriers to health-care decision-making and the coping process. Both 
interviewees and survey respondents identified challenges they experienced while coping with 
ADHD symptoms during pregnancy. Interestingly, the way in which women assessed their 
ability to cope was not through their strengths, but in what they identified as a weakness. A 
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major factor in the emotional and cognitive processes necessary for health-care decision-making 
is the woman’s knowledge of health-care choices. The experiences reported by these women 
indicate the importance the health-care provider as the central access point for information about 
management and care of ADHD during pregnancy. This data suggests there are additional areas 
in which provider knowledge can be helpful in primary support systems and recognition of the 
influence of contextual factors on the process of coping. Both quantitative and qualitative data 
acknowledge immediate family members and significant others or spouses as key individuals on 
whom the pregnant women rely for support.  
The information gained from this study may be used in the development of a group-
therapy curriculum focused on the themes identified in the data and in the evidenced-based 
literature. 
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CHAPTER 1: INTRODUCTION 
 
Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental 
disorder that manifests in childhood with predominate symptoms of hyperactivity and inattention 
(American Psychiatric Association, 2013). Initially considered to be a disorder solely confined to 
childhood and adolescence, recent research has identified that impairments can persist 
throughout the lifespan (Hechtman, 1999; Hinshaw et al., 2012; Klein et al., 2012). There is 
strong empirical evidence that suggests pharmacological and non-pharmacological treatments are 
efficacious in the management of adult ADHD symptoms (Shaw et al., 2012). Current guidelines 
recommend stimulant medication as the first-line treatment for both men and women with 
ADHD.  However, due to the lack of empirical testing when used during pregnancy, the safety 
profile is not fully understood; therefore, it is recommended that the medication is discontinued 
while the woman is pregnant and breastfeeding (Anderson, 1995; Besag, 2014). In addition, 
there is limited literature that describes the experience of women with ADHD who become 
pregnant (Besag, 2014; Freeman, 2014).  
This gap in knowledge creates a challenge for providers in the clinical setting, especially 
when the mother-to-be faces the dilemma of crucial health care decisions for herself and her 
unborn child. When it comes to women’s health issues, most women prefer to be involved in the 
decision-making process (Hundley, Ryan, & Graham, 2001; O'Cathain, Thomas, Walters, 
Nicholl, & Kirkham, 2002; Patel & Wisner, 2011). However, women are often left out of 
conversations surrounding their pregnancy or labor and birth care (Thompson & Miller, 2014). 
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Within the United States, this issue has gained recognition, and maternity care professional 
organizations, such as American Academy of Family Physicians (AAFP), American College of 
Obstetricians and Gynecologists (ACOG), American College of Nurse- Midwives (ACNM), and 
the Association of Women’s Health Obstetric and Neonatal Nurses (AWHONN), have joined to 
emphasize the importance of patient-centered care (Lawrence et al., 2012).  In a recent joint 
statement these organizations encouraged providers to incorporate patient-centered care in their 
practice stating “decisions about interventions should incorporate the woman’s personal values 
and preferences and should be made only after she has had enough information to make an 
informed choice, in partnership with her care team” (Lawrence et al., 2012, p. 147). This 
statement emphasizes the importance of shared information that facilitates patient involvement in 
healthcare decision making, especially when it comes to intra-partum care.  
Providers require greater knowledge of the woman’s experience of coping with ADHD 
symptoms when she no longer has support from psychopharmacology during her pregnancy. 
This knowledge is imperative for the process of shared decision-making and patient-centered 
care. A greater understanding of this process will facilitate discussion between the clinician and 
the pregnant woman regarding decisions surrounding her coping choices and the management of 
her symptoms (Barry & Edgman-Levitan, 2012).  Management of ADHD during pregnancy is a 
complex process and requires sensitivity of clinicians to the preferences and values of their 
patients to provide effective care. This DNP project will examine the process of coping in the 
context of healthcare decision-making and the experience of women with ADHD who became 
pregnant. 
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Background and Significance 
The etiology of ADHD has been linked to an interplay of genetic and environmental 
factors that disrupt dopamine and norepinephrine neurotransmission in a variety of brain 
structures (Kieling & Rohde, 2012). Twin studies around the world have revealed high 
heritability of ADHD validating the genetic component across ethnicities (Nikolas & Burt, 2010; 
Thapar, Cooper, Eyre, & Langley, 2013).  Research to improve understanding of the 
pathogenesis in ADHD has been on the rise due to increased prevalence in both children and 
adults (Akinbami, Liu, Pastor, & Reuben, 2011; Centers for Disease Control and Prevention, 
2005). 
The 2012 Health and Vital Statistics report estimates the prevalence of ADHD in children 
and adolescents at 9.5 percent in the United States (Akinbami et al., 2011; Bloom, Jones, & 
Freeman, 2012).  According to The National Co-Morbidity survey in 2006, ADHD affects 
roughly 4.4 percent of adults in the United States and 5.29 percent worldwide (Kessler et al., 
2006; Polanczyk, de Lima, Horta, Biederman, & Rohde, 2007; Polanczyk & Rohde, 2007). The 
literature pertaining to the gender distribution among adults with ADHD is difficult to quantify 
due to the lack of consistency among the methodologies used to estimate the prevalence (Knight 
et al., 2014). Therefore, this inconsistency becomes a barrier in trying to translate and interpret 
the prevalence of ADHD in adult women. However, two recent studies have yielded similar 
results indicating a slightly higher proportion of men among adults with ADHD (Knight et al., 
2014; Montejano, Sasane, Hodgkins, Russo, & Huse, 2011).  In addition, this same data also 
revealed consistency of a higher incidence rate, or new cases, of women with ADHD when 
compared to men (Knight et al., 2014; Montejano et al., 2011; Simon, Czobor, Bálint, Mészáros, 
& Bitter, 2009). This may suggest that providers are becoming increasingly more aware of the 
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characteristics specific to ADHD presentation in women.  To date, the best estimate of 
prevalence among adult women with ADHD was reported by Staller and Faraone (2006) using a 
conservative overall prevalence of 3% and sex ratio of 5:1, males to females. Using these 
numbers they estimated that least 1 million women in the United States and 32 million 
worldwide are affected by ADHD.  Unfortunately, there is no literature or data depicting the 
number of women impacted by their ADHD symptoms when they become pregnant (Freeman, 
2014).  
In an effort to demonstrate the potential impact of pregnancy among ADHD women, an 
estimation could be calculated using the estimated prevalence given by Staller and Faraone 
(2006) and the most recent birth rate calculation from 2011, 63.2 live births per 1,000 women 
(Martin, Hamilton, Ventura, Osterman, & Mathews, 2013). Assuming that all ADHD women 
had the desire and ability to become pregnant, then roughly 6.32% of women with ADHD would 
be faced with the decision of how to manage their symptoms during pregnancy based on my own 
calculation. 
Presentation of symptoms in adulthood varies considerably from those seen in children. 
Children usually display symptoms of hyperactivity, distractibility, inattention, and impulsivity 
(Pieroth, 2008).  Adults typically present with symptoms of functional and executive 
impairments, such as forgetfulness, inability to concentrate, and poor organizational skills 
(Pieroth, 2008).  Executive functioning involves five areas of daily behaviors:  time 
management, organization, motivation, concentration, and self-discipline (Weir, 2012). A recent 
study revealed that 89 to 98 percent of adults with ADHD are impaired in all five areas of 
executive functioning (Barkley & Murphy, 2011).  Males often present with externalizing 
features such as hyperactive/impulsive symptoms, while females present with internalizing 
5 
 
features associated with anxiety, depressive symptoms, or social withdrawal (Quinn, 2008).  The 
increased risk of anxiety and depression coupled with the impairments in memory and 
organization known to women with ADHD present additional challenges for the woman who is 
also adjusting to the physiologic and psychological changes that accompany pregnancy 
(Freeman, 2014). 
The majority of patients with ADHD are treated across the lifespan with the first line 
treatment of stimulant medication (Seixas, Weiss, & Müller, 2012).  All first-line medications act 
upon dopamine receptors within the neurotransmitter system to increase dopaminergic activity in 
the frontal lobe of the brain (Stahl, 2013; Waite, 2010).  The most commonly prescribed 
stimulants are methylphenidate (Ritalin), amphetamine salts (Adderall), and lisdexamfetamine 
(Vyvanse) (Stahl, 2013; Waite, 2010).  These medications reduce symptoms of ADHD while 
improving the process of working memory and other cognitive functioning (Ceraudo, 
Vannucchi, Massei, Perugi, & Dell'Osso, 2012).  When left untreated, adult ADHD can have 
significant lasting negative outcomes (Fredriksen et al., 2014; Stern, Pollak, Bonne, Malik, & 
Maeir, 2013). Women who choose to forego psycho-pharmacological support throughout the 
months of pregnancy and breastfeeding may be at greater risk for development of problems 
related to their job performance and interpersonal relationships (Alderson, Kasper, Hudec, & 
Patros, 2013).  
It is thought that a lack of sensitivity surrounding the distinctive symptom presentation in 
women, as well as other confounding factors, may contribute to an under-representation of 
women with ADHD. A rise in incidence rate is reflective of the efforts in education and research 
(Mahone, 2010; Nussbaum, 2012).  Inadequate knowledge of the complexities surrounding 
ADHD in women increases their susceptibility to un-diagnosis or misdiagnosis.  Co-morbidities, 
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such as depression and anxiety, are associated with improper diagnosis in childhood and 
subsequently can lead to the development of poor self-image and low self-esteem as adults 
(Mahone, 2010; Nussbaum, 2012; Rasmussen & Levander, 2009; Rucklidge, 2010).  This is 
consistent with clinical presentation reports, in which women endorsed more symptoms and 
displayed more impairment from impulsivity, anxiety and depression, as compared with men 
(Quinn, 2008).  Recent literature has also shown a correlation between obesity and ADHD 
among women, another confounding factor clouding the clinical picture (Cortese, Faraone, 
Bernardi, Wang, & Blanco, 2013). In clinical practice, recognition of ADHD in adulthood is still 
considered new, and management of this disorder can be challenging for many clinicians 
(Quintero, Balanza-Martinez, Correas, Soler, & Grp, 2013).   
A recent report from Express Scripts revealed an 85% increase of prescribed stimulant 
medication usage among women aged 24 to 28 from 2008 to 2012 as compared with the 36% 
increase seen among all adults (Armstrong, 2014). The astounding rise in stimulant use within 
this age group, coupled with the fact that they also have the highest rate of pregnancy, poses a 
significant problem (Ventura, Curtin, Abma, & Henshaw, 2012). 
The United States Food and Drug Administration (FDA) classifies ADHD medications as 
Pregnancy Risk category “C”, which are to be used only when the benefit to the mother 
outweighs the risk to the unborn child (Stahl, 2013).  Medications labeled “Category C” have 
shown adverse effects in animal studies, and there are no human data available (Gunatilake & 
Patil, 2013).  This gap in the literature regarding how to manage ADHD when a woman becomes 
pregnant confounded by the complexity of pregnancy increases the likelihood that healthcare for 
affected women will be inconsistent and possibly misinformed (Facchiano & Snyder, 2012). 
Problem Statement 
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Continuity of care in women with ADHD is being interrupted as a result of the limited 
information about the presentation of the disorder and best practices for management during 
pregnancy (Freeman, 2014).  Women with ADHD are currently faced with the significant 
decision of how to cope with their illness when recommendations to discontinue their stimulant 
medications are followed (Besag, 2014).  There is an abundance of literature to support shifts in 
healthcare to more patient-centric care with quality-driven outcomes (Millenson, 2014); yet, 
providers are challenged when they must continue care without evidence-based support or 
knowledge of their patients’ needs (Sadeghi‐Bazargani, Tabrizi, & Azami‐Aghdash, 2014).  
Without adequate knowledge, providers may face barriers in their efforts to implement patient-
centered care, especially when women prefer to be active participants in decisions regarding their 
healthcare during pregnancy (Haarenten et al., 2014; van Empel et al., 2011).  This presents a 
potential conflict between patient and provider due to a disconnect between the provider’s 
available resources and knowledge of the patients’ needs (Bright, Kayes, Worrall, & McPherson, 
2014).  It is important that barriers hindering the facilitation of patient involvement are removed, 
or at least minimized as the evidence supports that patient involvement improves quality of care 
(Bertakis & Azari, 2011; Lee & Lin, 2010).   
Considering the prevalence of ADHD within adult populations and the severity of 
impairment seen in women, it is important to gain a comprehensive understanding of how 
women with ADHD cope with symptoms (Biederman et al., 2010; Nussbaum, 2012; Polanczyk, 
Gwillcutt, Salum, Kieling, & Rohde, 2014). Information regarding how women cope and make 
decisions regarding management of their disorder will provide a greater understanding of patient 
preference, and promote preference-sensitive conversations surrounding management options 
between patient and provider (Chewning et al., 2012; Treweek et al., 2013).  Exploration of the 
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relationship between coping and decision-making can provide a greater understanding of the 
dynamics between women, cofounding factors and the management of their ADHD during 
pregnancy.  This DNP project will contribute to existing literature regarding the process of 
coping in the context of healthcare decision-making and the experience of women with ADHD 
who became pregnant. 
Study Aims 
 
The specific aims of this study are to: 
1. Identify multi-contextual factors that influence the process of coping with ADHD 
during pregnancy.  
2. Explore women’s perceptions of their coping with symptoms of ADHD during 
pregnancy. 
3. Identify the cognitive and emotional processes within the context of healthcare 
decision-making experience.  
4. Identify sources of social and emotional support during pregnancy for women 
with ADHD. 
5. Identify provider specific influences with shared decision-making during the 
process of coping for women with ADHD. 
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CHAPTER 2: REVIEW OF LITERATURE 
 
A review of the literature is necessary to identify those influential variables that guide a 
woman with ADHD in contemplating her management options.  Specifically, a review is 
conducted of how ADHD symptoms manifest in pregnant women and the confounding factors 
(hormones and perinatal stress) that interplay and influence the antepartum experience.  
Secondly, possible treatment and management options, a valuable component in the decision-
making process are evaluated.   Recognition of these variables, which may be less modifiable by 
a provider or primary support-giver, can facilitate a distinction among other influential variables 
that could be important to the woman with ADHD in her process of coping and deliberation. 
Exploration of ADHD in the context of pregnancy, and identification of influential components 
of decision-making when weighing the risk/benefit of health care choices is required to gain a 
greater understanding of the pregnant woman’s coping process.  
The data addressing ADHD symptomology in pregnancy is limited and lacks any 
systematic studies (Freeman, 2014).  A single study examined the relationship between 
symptoms consistent with an ADHD diagnosis and co-morbidities’ (Ninowski, Mash, & Benzies, 
2007).  Results revealed a positive correlation between comorbidities of anxiety and depression, 
and the presence of ADHD symptoms in expectant mothers; however, an ADHD diagnosis was 
never established by a provider, and only inferred, based on the answers to questionnaires 
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(Ninowski et al., 2007).  Literature relevant to ADHD in pregnant women acknowledges the lack 
of research unlikely related to the risk potential and overall limited awareness of ADHD in 
women. Experts emphasize the need for further study to gain a better understanding of 
symptomatology during pregnancy (Besag, 2014; Dideriksen, Pottegard, Hallas, Aagaard, & 
Damkier, 2013; Hærvig, Mortensen, Hansen, & Strandberg‐Larsen, 2014; Nonacs, 2014).  
There are inconclusive results from studies examining cognitive deficits directly linked to 
the physiology associated with pregnancy (including hormonal changes), and there are no 
published reports related to cognitive deficits in pregnant women with ADHD (Freeman, 2014).  
However, there are animal and human studies that show a positive correlation between changes 
in hormones and cognitive deficits.  Animal models suggest a significant relationship between 
female reproductive hormones and neurotransmitters having a direct correlation to mood 
disorders and cognitive deficits (Harsh, Meltzer-Brody, Rubinow, & Schmidt, 2009; Martel, 
Klump, Nigg, Breedlove, & Sisk, 2009). 
Hormones and Stress 
Estrogen is one of many hormones that dramatically increase during pregnancy.  It has 
been estimated that it would take a non-pregnant woman 150 years to produce the same amount 
of cumulative estrogens produced during a normal gestational time frame of nine months 
(Becker, 2001; Moore, 2013).  Female hormone fluctuations across the lifespan have been shown 
to increase vulnerability to mood disorders (Freeman, 2010; O'Hara, 2009; Rapkin & Akopians, 
2012). 
This drastic hormonal shift, along with other associated hormonal changes seen in 
pregnancy, has been shown to effect cognition in women, with or without mental illness.  
Research supports cognitive impairment has been linked to alterations in steroid and peptide 
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hormones (Workman, Barha, & Galea, 2012).  A comparative study examining cognition in 
pregnant and non-pregnant women found lower working memory scores and processing speeds 
in women who were pregnant or in the post-partum period (Henry & Sherwin, 2012).  Human 
studies have suggested a negative correlation between estrogen in the brain and conductivity of 
neurotransmission (Buckwalter, 1999; Fink, Sumner, Rosie, Grace, & Quinn, 1996; Onyper, 
Searleman, Thacher, Maine, & Johnson, 2010).  During adolescence, girls experience a surge of 
estrogen associated with puberty; in response, the brain produces more dopamine receptors in the 
brain (Arnold, 1996).  This may account for the rise in the severity of inattention symptoms seen 
in adolescent girls due to the increase of dopamine receptors and decreased dopaminergic 
activity associated with ADHD (Nussbaum, 2012; Quinn & Nadeau, 2002).  From this data, it is 
plausible to suggest that women with ADHD are perhaps more susceptible to inattention 
symptoms during their pregnancy. 
Stress is also a factor known to impact pregnant women emotionally and physically 
(Glover, 2014; Graignic-Philippe, Dayan, Chokron, Jacquet, & Tordjman, 2014; Richetto & 
Riva, 2014).  Evidence supports increased maternal stress is associated with negative outcomes 
for the fetus (Ibanez et al., 2012; Meltzer-Brody & Stuebe, 2014).  The impact of stress during 
the prenatal period can have negative outcomes, including spontaneous abortion and preterm 
labor and birth (Grizenko, 2008; O'Connor, Monk, & Fitelson, 2014).  
For pregnant women with ADHD, management of ADHD becomes especially important, 
as untreated symptoms are associated with poor outcomes, vulnerability to comorbidities, and 
perceived stress (Gjervan, Torgersen, Nordahl, & Rasmussen, 2012; Matthies, Philipsen, & 
Svaldi, 2012; Quinn, 2008).  ADHD is associated with neuropsychological deficits (attention, 
working memory, task switching, inhibition) that have a demonstrated relationship with 
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occupational impairments and overall decreased quality of life (Fredriksen et al., 2014).  
Pregnancy is associated with a variety of stressors such as the emotional aspect of motherhood 
and the physical changes that accompany pregnancy.  Women with ADHD may be at a 
disadvantage to handle these stressors due to their limited coping skills, and may have increased 
susceptibility to perinatal depression or anxiety (Garcia et al., 2012; Skirrow & Asherson, 2013).  
Antepartum stress, whether perceived or measured biologically, is linked to preterm labor, 
shorter gestation, and a negative impact on emotional and cognitive child development (Richetto 
& Riva, 2014).  However, recent studies have reported strong evidence to support maternal and 
fetal benefits associated with psychosocial interventions with the mother during the antenatal 
period (Sockol, Epperson, & Barber, 2011; Spinelli et al., 2013).   
In summary, women with ADHD who are pregnant are vulnerable to a greater number of 
stressors, especially when standard ADHD treatment is no longer considered safe. Without 
efficacious treatment modalities, pregnant women with ADHD are at greater risk of prenatal 
maternal stress, which has been linked with negative impacts on pregnancy outcomes (Glover, 
2014; Ronald, Pennell, & Whitehouse, 2010; Talge, Neal, & Glover, 2007).  Therefore, 
increased knowledge of how women with ADHD cope during pregnancy will guide the provider 
to more effective patient-centered care. 
Management Options During Pregnancy 
Currently, there are no standard treatment recommendations or clinical guidelines for 
management of ADHD in women, or management of symptoms for those who become pregnant, 
or for management of confounding factors that precipitate when delivering care during this 
transitional time (Freeman, 2014).  When first-line treatment recommendations are not 
appropriate for the individual adult, most clinical practice guidelines recommend psychosocial 
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interventions such as psychotherapeutic modalities rooted in a cognitive approach (Seixas, 
Weiss, & Muller, 2012).  However, none of these address the variations in presentation of 
ADHD in women, nor how to manage the disorder when a woman with ADHD becomes 
pregnant.  In addition, these guidelines conflict with recommendations by women’s health 
specialists that suggest discontinuation of any medication that is unnecessary (Lockwood & 
Magriples, 2014).  
Stimulant Medications.  There are a few published studies examining adverse outcomes 
of human fetal exposure to stimulants during the treatment of ADHD. Studies have focused 
primarily on methylphenidate and amphetamines.  The majority of studies looking at 
amphetamine exposure revealed inconsistencies in the amounts and routes administered, and 
included subjects who abused substances (Besag, 2014; Humphreys, Garcia-Bournissen, Ito, & 
Koren, 2007). Therefore, it would be difficult to generalize this information to make treatment 
decisions.  
Methylphenidate is the active metabolite in Concerta and Ritalin.  Methylphenidate is 
derived from the amphetamine family, and studies have established that amphetamines cross the 
placental barrier in animals, but no data is available on fetal exposure (Burchfield, Lucas, 
Abrams, Miller, & DeVane, 1991; Shah & Yates, 1978).  Characteristics of drugs that cross the 
placenta are not protein-bound, are lipid-soluble, weakly acidic, hold a molecular weight less 
than 500 daltons and have a long half-life (Taddio, 2001).  Methylphenidate has low-protein-
binding capability and a molecular weight of 269.8, suggesting that it could cross the placental 
barrier (Taddio, 2001).  Studies in rats and rabbits have shown decreased gestational weight from 
methylphenidate exposure (Beckman, Schneider, Youreneff, & Tse, 2008). The limited amount 
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of relevant data does not suggest an overt risk if exposure to methylphenidate occurs; however, 
there is no information on fetal brain development when exposure does occur.  
Two recent studies examined adverse outcomes and exposure in utero to methylphenidate 
(Haervig, Mortensen, Hansen, & Strandberg-Larsen, 2014; Pottegård et al., 2014).  One study 
from Denmark compared the rate of congenital defects in children exposed to methylphenidate 
during the first semester versus those who were not exposed (Pottegård et al., 2014).  The 
research yielded no statistically significant difference between the two groups, suggesting that 
in-utero exposure posed no greater risk than with those among the general population.  Another 
recent study in Denmark examined stimulant exposure, at any point in 480 pregnancies, 
stimulants included methylphenidate, modafinil and amoxetine (Haervig et al., 2014).  Analysis 
of data from the national registry yielded similar results, finding no increased risk associated 
with congenital defects with stimulant exposure (Haervig et al., 2014).  However, this study did 
find statistical significance between spontaneous or therapeutic abortion rates and fetal exposure 
to stimulants (Haervig et al., 2014).  Also of interest in this study, women with ADHD were 
found to be socially disadvantaged regardless of their stimulant use during pregnancy, therefore 
results are not generalizable (Haervig et al., 2014).  A recent systematic review of fetal 
methylphenidate exposure used existing published data to review adverse outcomes. This study 
identified 180 exposures, and found 4 exposures (2.2%) had major malformations, which was 
comparable to the relative risk seen in the general population (Dideriksen et al., 2013).  
There is limited information on the effects of methylphenidate and amphetamine in 
infants who are breastfed.  A small study of infants, 3 to 10 months in age, examined the plasma 
levels obtained from three infants exposed to dexamphetamine (brand name Dextrostat or 
Dexedrine) from breastmilk (Ilett, Hackett, Kristensen, & Kohan, 2007).  Samples were taken 
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less than four hours from maternal intake of dexamphetamine. In one infant dexamphetamine 
was not detected, while the other two infants showed concentrations of plasma dexamphetamine 
at 6% and 14% (Ilett et al., 2007).  A handful of case reports presented information on the effects 
of breastfeeding mothers while concurrently taking methylphenidate (Bolea‐Alamanac, Green, 
Verma, Maxwell, & Davies, 2013; Hackett, Ilett, Kristensen, Kohan, & Hale, 2005; Spigset, 
Brede, & Zahlsen, 2007). These case reports showed that Methylphenidate was not detected in 
the blood samples of the infants and none of the mothers reported adverse effects in their infants 
from exposure (Bolea‐Alamanac et al., 2013; Hackett et al., 2005; Spigset et al., 2007). 
Psychotherapy. Psychosocial interventions using psychotherapeutic modalities rooted in 
cognitive approaches are often used as an adjunct treatment with medication when treating 
ADHD (Miguel Seixas et al., 2012). These treatments focus on improvement of executive 
functioning deficits that often accompany the overall impairments seen in adult ADHD (Barkley 
& Murphy, 2011).  Reviews of studies that examine psychosocial interventions with ADHD in 
the general adult population include studies related to Cognitive Behavior Therapy (CBT), 
Dialectical Behavior Therapy (DBT), and Mindfulness (Solanto, 2014).  Also, more recent 
studies have found effects of physical activity to improve cognitive deficits in the brain (Berwid 
& Halperin, 2012). 
Cognitive Behavior Therapy. Cognitive Behavior Therapy (CBT) is grounded in 
reframing conscious cognitions to address maladaptive behaviors or thoughts that stem from 
irrational thoughts or negative associations (Knouse & Safren, 2010).  For example, a repeated 
experience of frustration in an effort to complete a task would promote a perception of 
inadequacy in oneself.  CBT seeks to identify patterns of negative, irrational thoughts, and to 
challenge the accuracy of such thoughts. Through the process, the patient learns to recognize this 
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maladaptive thought pattern and reframe the individual thoughts to ones that are more positive 
and accurate for the situation.  CBT treats ADHD symptoms through the strengthening of the 
individual’s coping skills, thereby reducing functional deficits, which are often associated with 
low self-efficacy (Mongia, 2012). Randomized controlled trials (RCT) evaluating the use of CBT 
have established efficacy as an adjunct treatment in managing residual impairments such as 
organizational and time management skills, neither of which are addressed by medication 
(Mongia, 2012; Retz, Stieglitz, Corbisiero, Retz-Junginger, & Rosler, 2012). Only recently has 
there been an RCT comparing CBT versus medication in ADHD to explore the significance 
between the two treatment options.  As previously suggested, CBT and medication were 
effective in reducing symptoms, but CBT was independently shown to be effective without the 
use of medication (Weiss, 2012).  All these studies demonstrated improvement in ADHD 
symptoms with brief episodes of treatment ranging from 14-24 weeks, with a similar sample size 
of approximately 50. CBT provides even more support as an effective treatment during 
pregnancy.  However, variations in measurement tools, number of treatment sessions, study 
structure, lack of equally dispersed male-to-female ratio, and sample size, hinder the application 
of this method to a general population (Mongia, 2012). 
Dialectical Behavior Therapy. (DBT) is a psychotherapy originally developed to treat 
Borderline Personality Disorder (Solanto, 2014).  However, it has been adapted to treat ADHD 
because of the similarity of symptomatology such as emotional dysregularity, impulsivity, and 
low self-esteem (Fleming, McMahon, Moran, Peterson, & Dreessen, 2014).  The adapted DBT is 
provided in a group setting that meets for 13 weekly sessions to discuss a different module each 
week (Solanto, 2014).  There is limited evidence to support the efficacy of this modality used to 
treat ADHD adults as monotherapy (Hirvikoski et al., 2011).  However, three recent RCT’s 
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evaluating DBT involved a mixed sample of adults, with and without concurrent medication use 
and demonstrated a reduction in ADHD symptoms (Fleming et al., 2014; Hirvikoski et al., 2011; 
Philipsen et al., 2013).  There are also two less systematic studies utilizing an adapted form of 
DBT that displayed similar results in adults (Hesslinger et al., 2002; Philipsen et al., 2007). As 
this approach of DBT therapy does not focus on skills of executive function, it is recommended 
for adults with ADHD whose predominant symptoms are impulse control and issues with 
maintaining healthy interpersonal relationships (Solanto, 2014). 
Mindfulness. Mindfulness-based approaches use guided practice to increase awareness 
of thoughts and present experiences in a non-judgmental context.  Meditation has been shown to 
regulate attention by altering neural activity, including dopamine levels, and through change of 
attention networks in the brain (Jha, Krompinger, & Baime, 2007; Kjaer et al., 2002; Newberg et 
al., 2001; Singh & Narang, 2014).  Mindfulness may be used to target behavioral symptoms, 
inattention and impulsivity, and other secondary symptoms such as stress, depression, and 
anxiety (Zylowska et al., 2008).  There are limited studies investigating the effect of 
mindfulness-based interventions that specifically target ADHD symptoms (Krisanaprakornkit, 
Ngamjarus, Witoonchart, & Piyavhatkul, 2010).  However, in a recent pilot study with 18 
ADHD adults mindfulness demonstrated efficacy for the improvement of executive functioning 
and emotional regulation skills (Mitchell et al., 2013).  Furthermore, several studies have 
examined the use of mindfulness in improvement of emotion regulation and attention (Keune, 
Bostanov, Hautzinger, & Kotchoubey, 2013; Rubia, 2009; Zeidan, Johnson, Diamond, David, & 
Goolkasian, 2010).  This appears to be a promising intervention for symptom management in 
adults with ADHD, however, the variation in study design and indication for use in higher 
functioning individuals would make this difficult to replicate in clinical practice. 
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Physical Exercise. There are no studies that examined the direct link of physical exercise 
on improvement of ADHD symptoms.  Physical exercise has been shown to have positive short-
term gains in working memory and a long-term impact on prevention of cognitive disorders such 
as dementia and Alzheimer’s (Archer & Kostrzewa, 2012; Larson, 2008).  In addition, physical 
exercise proves to be an effective non-pharmacological treatment for depression and anxiety 
symptoms, and enhances cognition (Hopkins & Bucci, 2010; McKercher et al., 2009).  It is 
thought that the relationship between physical activity and neuropsychological findings are 
rooted in the brain’s ability to perform neurogenesis, directly impacting the connectivity of 
neurotransmission and increasing protective factors, thus improving performance (Archer & 
Kostrzewa, 2012; Berwid & Halperin, 2012).  The majority of literature evaluating the 
relationship between physical exercise and cognitive effects are of experimental design, using 
smaller sample sizes that do not have an ADHD diagnosis (Chang, Labban, Gapin, & Etnier, 
2012). Studies that aimed to examine the effects of physical exercise in subjects with ADHD 
were predominately those testing children (Berwid & Halperin, 2012; Gapin, Labban, & Etnier, 
2011; Grassmann, Alves, Santos-Galduróz, & Galduróz, 2014). A recent study was demonstrated 
cognitive improvement in adults with continuous exercise over four weeks; however, the 
participants were not evaluated for the presence of ADHD (Hopkins, Davis, Vantieghem, 
Whalen, & Bucci, 2012).  In summary, there is sufficient support to demonstrate a significant 
relationship between physical exercise and improved cognition.  However, due to the variety of 
study designs and age of participants, further research is needed with adult participants with 
ADHD.  These studies require a more controlled study design to identify whether benefits are 
associated with individual physical exercise sessions, or after sustained activity. 
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Summary of Management Options. The literature provides adequate support for 
alternative treatments to support management of ADHD symptoms during pregnancy, given 
there is a lack of specific guidelines for this population.  CBT provides the most robust empirical 
evidence, and also provides treatment for co-morbid symptoms.  However, more research is 
needed to provide support for the use of CBT without medication in adults before it is considered 
a standard non-pharmacological treatment choice.  Mindfulness and DBT continue to show 
promise as alternative treatment options as they have been empirically shown to alleviate 
symptoms in a short duration and are relatively cost effective (Goodman & Tyer-Viola, 2010; 
Solanto, 2014). Physical exercise, an existing recommendation during pregnancy, may also 
provide improvement in working memory, cognitive enhancement, and reduction in associated 
stress (Barenberg, Berse, & Dutke, 2011; Etnier, Nowell, Landers, & Sibley, 2006; Hopkins et 
al., 2012).  Preliminary open studies have shown improvement in symptom management with 
use of physical activity in children with ADHD (Berwid & Halperin, 2012).  However, there are 
no specific data regarding the benefit of physical exercise for adults with ADHD.  It seems 
reasonable to suggest the limited efficacy of exercise in children would also exist for 
management of symptoms in adults. 
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CHAPTER 3: CONCEPTUAL FRAMEWORK 
 
The Coping in Deliberation (CODE) Framework 
The conceptual framework chosen for this project focuses on a preference-sensitive, 
decision-making process from the patient’s perspective that reflects the patient’s values and 
situation.  Patient-centered care was defined in the Institute of Medicine’s (IOM) report, 
Crossing the Quality Chasm, as “providing care that is respectful of and responsive to individual 
patient preferences, needs, and values and ensuring that patient values guide all clinical decisions 
and ensuring that patient values guide all clinical decisions” (Institute of Medicine, 2001, p. 6). 
An essential characteristic of patient-centered care is participation of patients and families in 
their healthcare decisions (Institute of Medicine, 2001).  Providers who provide patient-centered 
care must be knowledgeable and sensitive to the needs and preferences of their patients (Barry & 
Edgman-Levitan, 2012).  Shared decision-making promotes patient involvement and is linked to 
positive outcomes such as reduced overall healthcare cost and greater utilization of treatment 
options with clear benefits (Barry & Edgman-Levitan, 2012; Veroff, Marr, & Wennberg, 2013). 
In an effort to better align with patients' preferences and values, the provider becomes a partner 
and engages in dialogue and exploration with the patient regarding care choices (Guyatt et al., 
2004).  This dialogue becomes important when faced with the uncertainty of healthcare decisions 
because patients prefer varying levels of participation in the shared decision-making process 
(Brown et al., 2012; Fraenkel, 2011).  Literature shows that patients who may have initially been 
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reluctant to play an active role in making healthcare decisions may later decide to become more 
actively involved, if given more information about their options (Brown et al., 2012; Chewning 
et al., 2012; van Tol-Geerdink et al., 2006).  The Coping in Deliberation (CODE) Framework is 
a model specifically designed for situations in which there are ambiguous treatment 
recommendations (Witt, Elwyn, Wood, & Brain, 2012), as is the case for women with ADHD 
when they become pregnant.  The application of this framework offers a comprehensive 
approach toward understanding how a woman copes with managing her ADHD symptoms once 
the management options have changed.  
The CODE framework provides a model for appraisal and deliberation in the context of 
preference-sensitive healthcare choices (Witt et al., 2012).  A preference-sensitive choice is 
described as one in which no clear medical guidance is available and requires exploration of 
patient values and preferences (Witt et al., 2014).  The authors of this framework suggest that 
individual coping choices result from a transactional process of appraisal and deliberation (Witt 
et al., 2012).  The framework addresses the importance of integration of the coping process with 
decision-making (Elwyn & Miron-Shatz, 2010; Janis & Mann, 1977; Power, Swartzman, & 
Robinson, 2011).  
The CODE framework incorporates constructs of Conflict Theory and system variables 
for stress from the Transactional Model (Lazarus & Folkman, 1987; Lazarus, DeLongis, 
Folkman, & Gruen, 1985; Witt et al., 2012).  Until recently, theories of coping and decision-
making were mutually exclusive and did not acknowledge the influence of one on the other 
(Power et al., 2011).  The foundation of the CODE framework builds on previous research and 
interlinks the processes of coping and deliberation while maintaining sensitivity to the 
individual’s integrity (Balneaves & Long, 1999; Power et al., 2011; Witt et al., 2012).  
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The framework identifies four deliberation phases, and within each phase the patient is 
guided through three processes of appraisal ( ` Appendix 1) (Witt et al., 2012). The four 
deliberation phases are: a) disclosure of the risk or health threat, b) discussion of choice, c) 
preference construction, and d) the decision (Witt et al., 2012).  When the patient is faced with 
the health threat, contemplation occurs in the context of its identity, timeline, cause, 
consequences, and what is within the patient’s control (Power et al., 2011).  As the patient 
discusses options, the second phase of deliberation, there is a focus on both emotional and 
cognitive elements throughout the phase.  Specifically, the patient actively engages in the “What 
if?” scenarios with each of the possible choices, and weighs the risk/benefit, while also 
considering the emotions experienced with each option (Elwyn & Miron-Shatz, 2010).  During 
preference construction, the third deliberation phase, the patient may be heavily influenced by 
contextual factors and circumstances (Elwyn & Miron-Shatz, 2010).  Of the deliberation phases, 
preference construction seems to be the least systematic because of the variability in how it 
develops (Lichtenstein & Slovic, 2006).  For example, preference could change in a matter of 
minutes in light of new information.  The actual decision occurs in the final phase of 
deliberation, after preference construction is complete and a preferred option has been selected 
by the patient (Witt et al., 2012).  It is important to note that the decision does not always 
represent a treatment decision; the patient may decide to avoid the decision all together or 
transfer the decision to someone else, such as a provider or significant other (Witt et al., 2012).  
Within each stage of deliberation three processes of appraisal occur before the patient progresses 
to the next phase. 
The first process begins with primary appraisal, followed by a secondary appraisal and 
finally, with the process of coping (Witt et al., 2012).  In primary appraisal, cognitive and 
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emotional aspects surrounding the perceived significance of the stressor or threat to the patient 
are processed (Lazarus & Folkman, 1987).  The patient assesses the meaning, relevance, and 
strength of the threat during this process (Witt et al., 2012).  Questions in primary appraisal assist 
the patient in exploring the nature of the threat and feelings about it (Witt et al., 2012). The 
secondary appraisal is the evaluation of perceived control in response to the stressor or external 
event through utilization of resources and skills at the patient’s disposal (Lazarus & Folkman, 
1987).  This secondary appraisal also has cognitive and emotional aspects; however, the focus is 
on the evaluation of the patient’s coping response (Witt et al., 2012).  The patient is guided to 
assess the coping resources that may be helpful in dealing with the threat, such as availability of 
social support or having a positive outlook.  The final process of coping is primarily focused on 
the  selection of a coping strategy (Witt et al., 2012).  The selection of a coping strategy can be 
influenced by the patient’s preferred coping style, or personal factors such as values, beliefs or 
self-efficacy (Witt et al., 2012).  The framework proposes the effectiveness of the coping 
strategy is largely determined by whether or not the patient judges it appropriate for the 
circumstances (Witt et al., 2012). 
Movement through each appraisal process and deliberation phase is facilitated by a series 
of questions that address different considerations important in the decision-making process.  The 
questions are adapted to serve as prompts to elicit the patient’s thoughts and concerns and to 
assist the healthcare provider’s understanding of the patient’s preferences (Witt et al., 2012) 
(Appendix 2).  Though depicted as a linear process, the framework is a dynamic, iterative 
process that promotes re-appraisal and fluidity between the deliberation phases (Witt et al., 
2012).  This is intentional to allow for adaptability in the differences among individuals and to 
recognize the potential need for alteration of coping strategies as appraisal and deliberation 
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continue (Witt et al., 2012).  If the desired outcome was not achieved, the patient may circle back 
to re-appraise the threat and subsequently make adjustments to the coping strategy (Witt et al., 
2012).  For example, a woman who is at high risk for developing breast cancer and initially 
chooses avoidance to cope, may become increasingly anxious, re-appraise her risk, and choose a 
different coping strategy to more effectively decrease her anxiety.  The relationship between 
emotion and cognition in each of the processes is not necessarily linear or rigid (Witt et al., 
2012).  Emotions are influential in the cognitive process of the patient during primary and 
secondary appraisal (Lazarus & Folkman, 1987).  For example, anxiety could magnify the 
perceived threat in primary appraisal or become a barrier in secondary appraisal by inhibiting the 
patient’s ability to identify possible resources for coping (Witt et al., 2012).  
Consolidation is the final stage in the CODE framework, and is separate from the 
deliberation phases.  Described as a “coping mechanism designed to defend a decision from 
regret in the future”, the consolidation phase acknowledges the importance of consequence as a 
component of any decision-making framework; the outcome of the decision is something that 
stays with the patient (Witt et al., 2012, p. 260).  In an effort to accept and support their choice, 
patients’ experience attractiveness restructuring (Svenson, Ampara Ortega, Andersen, Sandberg, 
& Svahlin, 1994).  This restructuring process during the consolidation phase assists patients to a 
place of acceptance with the decision-making, and allows the ability to reshape their perspective 
as to how they achieved the outcome; thereby, influencing future decision-making (Svenson et 
al., 1994).  
The integration of the coping and decision-making a process encompasses a holistic 
approach and depicts a more accurate representation of individual experiences in in the context 
of real life (Balneaves & Long, 1999; Power et al., 2011; Witt et al., 2012). The CODE 
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framework describes the deliberation process in the context of emotional and cognitive thinking 
with the provision of a systematic approach and an aim to provide insight into the intangible 
process of patient decision-making (Witt et al., 2012; Witt et al., 2014).  Therefore, through the 
shared decision-making process, providers are instrumental not only with engagement, but also 
with assessment of patient-support requirements and assistance with provision of those supports 
(Stiggelbout et al., 2012).  This process promotes patient engagement and patient-centered care, 
key components for improved outcomes for healthcare decisions (Barry & Edgman-Levitan, 
2012; Stewart et al., 2000). 
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CHAPTER 4: METHODS 
 
Design. This project was a mixed methods design including qualitative data from semi-
structured interviews and quantitative data from an online survey administered by Qualtrics. This 
approach was selected to provide a broader perspective (survey) that was supplemented with the 
richness of qualitative data (interview).   Due to the complexity of the coping process women 
who have been diagnosed with ADHD experience, and the scarcity of information currently 
available to assist providers, this approach was chosen to obtain preliminary data. Institutional 
Review Board approval to conduct the study was obtained. 
Sample. The sample consisted of two female interviewees and 33 survey participants. 
The inclusion criteria were the same for both groups. The inclusion criteria were: women, 
between the ages of 18-40 diagnosed with ADHD by a psychiatrist or Psychiatric Mental Health 
Nurse Practitioner (PMHNP) pre-pregnancy, and delivered a baby less than 5 years ago.  
Recruitment of the interviewees occurred during a one-month period facilitated by 
providers at a local outpatient agency. Providers were asked to share study information and 
inclusion criteria with anyone who might meet inclusion criteria and be willing to participate. 
Interested participants were asked to call the agency to be scheduled for an interview. The 
agency identified one staff member to help coordinate the interviewees, as well as obtain initial 
verbal verification of inclusion criteria prior to being scheduled for the interview.  
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Recruitment of survey participants occurred through social media, professional networks 
and the University of North Carolina at Chapel Hill (UNC) Listserv via a recruitment flier 
(Appendix 3). In addition, a website was developed with information about the study and 
provided the survey link for those willing to participate.  
Utilizing a qualitative approach, two in-depth interviews were conducted with women 
who met study criteria.  The two interviewees opted to choose their own pseudonym to uphold 
confidentiality. The first woman interviewed was “Caroline” and the second interviewee was 
“Naomi”. 
Caroline is a 29-year-old married Caucasian female with a bachelor’s degree who works 
in business. She is a first time mother of a four-month-old girl. Caroline was diagnosed with 
ADHD at the age of 13 and denies any other co-occurring psychiatric diagnoses. She began 
taking stimulant medication at the time of her diagnosis and discontinued her medication upon 
discovering she was pregnant in 2014; she resumed her medication after breastfeeding ended. 
Her primary care provider managed the stimulant medication (Adderall XR) for her ADHD.  
Naomi is a 30-year-old African American engaged female who has completed some 
college credit and is currently a homemaker.  She is a mother of a 17-month-old girl and was 
four months pregnant with her second child at the time of the interview. Naomi reports being 
diagnosed with ADHD at age five, with bipolar disorder as a teenager.  Six months prior to her 
first pregnancy she reported being treated with Concerta and another medication for sleep.  
During her last pregnancy she reported being treated with Latuda for a short period for 
depression and has recently resumed Latuda during this pregnancy for difficulty sleeping. She 
reports that her last dose of Concerta was prior to discovering she was pregnant with her 
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daughter over two years ago. Naomi reports seeing a psychiatric provider for her mental health 
needs since she received her first psychiatric diagnosis. 
Setting. The participating agency from which the interviewees were recruited was a large 
provider of psychiatric and mental health services across the lifespan throughout the state of 
North Carolina. The agency used in this project was located in the Research Triangle of North 
Carolina, and serves patients with severe and persistent mental illness through the provision of 
psychiatric assessments, individual and family therapy, and medication management.  
The setting for the survey participants was primarily virtual to include the study website, 
professional organizations; the PI’s social media account (Facebook) and the UNC listserv. 
Healthcare provider agencies in outpatient clinics were used to post fliers for advertisement of 
the website and URL for the survey.  
Data Collection 
Qualitative. A separate, single interview was conducted with each of the interview 
participants recruited by providers within the agency. Consent was obtained (Appendix 4) for the 
process of identifying and scheduling the interviews. Each interviewee received a $40.00 Target 
gift card as an incentive to participate.  
 A semi-structured interview format consisting of 22 open-ended questions was developed 
by the investigator and was adapted from the review of literature and adapted to fit the cognitive 
and emotional elements of decision-making as discussed in the CODE Framework (Appendix 5). 
The interview format, according to the CODE Framework was customized from four core 
questions to elicit information relating to each interviewee’s coping process.  These four 
questions were: 
 What were the antecedent circumstances in making this decision? 
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 What is at stake in making this treatment decision? 
 What are my options in making this treatment decision? 
 What are the adaptational outcomes of this decision? 
Basic demographic data was collected during the interview and included: 
 Employment, marital, insurance status 
 Co-morbidities 
 Highest level of education completed 
 Age during last or current pregnancy, number of pregnancies 
Quantitative.  A one-time, online survey administered by Qualtrics™ was offered to 
obtain information about women’s perceptions of their coping with ADHD symptoms during 
their pregnancy (Appendix 6). The Qualtrics survey is approved for protection of sensitive 
information. The survey questions were developed from the review of literature and the CODE 
framework in a similar process as the qualitative interview questions, and then adapted for an 
online survey format. The survey participants entered the survey via a single URL. In an effort to 
increase the rigor of methodology and quality of the information retrieved from the survey, the 
questions were reviewed and revised through consultation with the Odum Institute for Research 
in Social Science. The survey was active for 30 days.   
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CHAPTER 5: DATA ANALYSIS 
 
A mixed methods approach using a convergent design involved the independent 
collection and analysis of both qualitative and quantitative data, with the intention of connecting 
the two sources through an integrated analysis (Creswell, 2014). Therefore, data collection 
occurred during the same time and phase to collect equally weighted strands of qualitative and 
quantitative of data. Independent analysis occurred before the data was interfaced for a larger 
interpreted meaning.  An effort was made to facilitate compatibility among the qualitative and 
quantitative data by establishing identical inclusion criteria so that each source of data would 
originate from the same population. In addition, parallel questions were derived from the same 
conceptual framework and process for use in collecting the qualitative and quantitative data. 
Parallel data analysis was conducted so that the collection and analysis of both data sets was 
carried out separately and the findings are not compared or consolidated until the interpretation 
stage (Ostlund, Kidd, Wengstrom, & Rowa-Dewar, 2011). The use of a concurrent approach, in 
which the data is merged into one data source, is not feasible for this study given the differences 
between the qualitative and quantitative data collection processes (Ostlund et al., 2011). 
Similarly, the sequential approach was also not applicable for this analysis, as the data was not 
dependent on one another (Ostlund et al., 2011).  
Qualitative.  Case study methodology, using a purposeful sampling approach was used 
for in-depth analysis of the cases (Creswell, 2012).  Specifically, an instrumental case study 
design was utilized, with the focus of study being the phenomenon experienced (process of 
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coping), rather than the case itself (female interviewee) (Stake, 1995). Therefore, the process of 
coping was the unit of analysis, and was bounded by the time when pregnancy was recognized, 
the decision was made to continue or discontinue stimulant medication, and stimulant medication 
was resumed.  
 The analysis was performed at two levels for the multiple case study design: 
within each case and across the cases (Stake, 1995). Each case was analyzed individually for 
themes, and then collectively for commonalities and differences. This revealed the extent to 
which the identified internal and external factors had similar or different effect on the cases in 
relation to their coping experience. Finally, the meaning of the themes and patterns among the 
cases was interpreted.  
The qualitative data analysis process was guided by six stages: 1) Code Manual, 2) Code 
Reliability, 3) Application of Codes, 4) Data Summary, 5) Connecting the Codes, and 6) Theme 
Confirmation (Appendix 7). The process began with the development of a code manual  
(Appendix 8). This initial stage organized the data into similar categories for interpretation 
(Fereday & Muir-Cochrane, 2006). Codes were derived from the four phases of deliberation and 
process of coping (CODE Framework). Each code was given a name or label, a definition of the 
theme, and description of the context. 
The second stage, code reliability, was used to determine the applicability of the codes to 
the raw data (Fereday & Muir-Cochrane, 2006). A second reviewer evaluated possible 
discrepancies with code assignments, and any discrepancies were resolved through review of the 
raw data.  Application of codes was the third stage and initiated an iterative process through 
summarization of the data and loosely identifying themes while reading and listening to the data 
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(Fereday & Muir-Cochrane, 2006). The same iterative process was conducted for both 
interviews. 
 The fourth stage, data summary identified key phrases of text with the codes to facilitate 
meaning and the emergence of patterns (Fereday & Muir-Cochrane, 2006). Corresponding 
phrases or text from each interview were extrapolated and organized by code was conducted in 
this fourth stage (Appendix 9 and 10). Connection of the codes, the fifth stage, is where key 
phrases according to each interview were compared for differences and areas of consensus was 
completed (Fereday & Muir-Cochrane, 2006). This stage was more interpretative, as a central 
point of this stage results in the recognition of themes that occurred throughout the process 
(Appendix 11)  (Fereday & Muir-Cochrane, 2006). 
The quotes with assigned codes were combined as one unifying theme in the final and 
sixth stage, theme confirmation.  It is at this stage where all the quotes with their assigned code 
are combined and one unifying theme emerges.  The result of this process resulted from further 
data clustering, yielding one source, according to the theme identified and reviewed (Fereday & 
Muir-Cochrane, 2006). This final stage serves to solidify how the themes generated uncover the 
meaning of coping to women with ADHD during pregnancy. 
The sixth and final stage consisted of further data clustering which resulted in a unifying 
theme.  These themes emerged from the assigned quotes for each code. It is the process in this 
final stage that further defines the experiences of coping for these women. 
Quantitative. The Qualtrics-administered survey included one consent question, four 
mandatory questions to screen for inclusion criteria, seven demographic questions, and twenty-
four questions about the woman’s experience of coping with ADHD symptoms during 
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pregnancy. Thirty-three respondents consented to participate in the survey; however only 30 
respondents met inclusion criteria. Therefore, these three respondents were not included in the 
analysis. The data generated from 30 respondents was analyzed using R statistical software.  
The primary analyses were descriptive due to sample size, and frequency distributions were 
computed for all survey questions. Analyses were conducted to compare survey responses for 
primiparous (first pregnancy) and multiparous (more than one pregnancy) mothers using a 
contingency table. Our sample size was 30 participants and consequently underpowered to use 2 
tests. Participants were not required to answer any questions outside of the screening questions; 
therefore the number of respondents will only be reported when the number (n) is less than 30. 
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CHAPTER 6: RESULTS 
 
Qualitative: Through the six stages of data analysis the transcripts of Naomi and 
Caroline were reviewed three full times resulting in the identification of three main themes: 
prenatal patient-centered care (PCC), primary support, and maternal role or “mothering”. The 
formulation of these three themes emerged following the fourth and fifth stage of data analysis 
(Appendix J) and was validated during the final stage: Theme Confirmation (Appendix K). 
These three themes further define important elements of a shared experience for these two 
women who coped with ADHD during their pregnancy. Each of these themes is discussed in 
detail. 
Lack of Prenatal Patient-centered Care. Patient-centered care was defined by the 
Institute of Medicine’s (IOM) in their report Crossing the Quality Chasm, as “care that is 
respectful of and responsive to individual patient preferences, needs, and values” (Institute of 
Medicine, 2001, p. 6). Both women expressed healthcare experiences that lacked patient-
centered care during their prenatal period. Both women were unable to recall any discussion at 
any time before or during their pregnancy with their psychiatric provider or their OB-GYN 
provider about how their ADHD symptoms would be managed during pregnancy and 
breastfeeding.  
Caroline  “…but it never got mentioned or brought up to me …and I guess I 
didn’t really probe them for support in that area ‘cause I kind of felt like their specialty 
was in taking care of myself and the baby during pregnancy…I just knew that wasn’t 
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really where I was going to get support …”.  While Naomi shares, “No, they made me go 
off of it (the medication)…the doctor said you can’t be on ADD medicine while you are 
pregnant”.   
Both women shared an experience of interrupted continuity of obstetric care; 
Naomi stated 
“… I don’t like the fact how…[they]... couldn’t deal with my high risk so they 
had to send me to another prenatal care place unlike the place I am at now, even though I 
am high risk they can still treat me (current site) even though I am high risk and I like 
that”.   
Caroline stated, “So it’s weird, it’s like your primary care physician prescribes 
you medication and then once I became pregnant I just really stopped seeing them all 
together. And so those were always the conversations I would have with my primary care 
provider. My OB/GYN never talked to me about Adderall or ADD or anything like that”. 
For example, in response to being asked what would have been helpful, Caroline stated, 
“[To] know what other options there are out there, that are safe for you and safe 
for child - would that be medication or whether that would be just recommended that 
during this time ‘Why don’t you meet with someone bi-weekly or weekly’”. Caroline 
reiterates this when asked specifically about conversations about alternative options, such 
as psychotherapy from her provider, “…I think that would have probably been a benefit 
being pregnant and even after pregnancy with breast-feeding and everything like that.” 
Naomi shared a similar response when asked if there was anything her provider 
could have done to be more helpful, “[To know] what they could have put me on, even if 
it wasn’t that strong, but at least something to help control my ADHD and my impulses 
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while I am pregnant.” When asked if it would have been helpful for someone to have 
specifically discussed with her some options, she responded “Exactly”.  
The reported experiences of these two women suggest the need for improvement with 
respect to the healthcare they received; specifically, the need for continuity of care and 
patient/provider conversations about options. These two needs are currently identified by our 
healthcare system as important to the quality of care patients receive (Barry & Edgman-Levitan, 
2012).  
Primary Support.  Although, the term “primary support” may be used to identify 
multiple sources of closely connected relationships upon which one might rely, for these two 
women the term primary support consisted of family and family “figures.”  The importance of 
this type of support and its impact on their coping was mentioned repeatedly throughout both 
interviews.  Caroline identified her husband, mother, and mother-in-law as her primary support 
network.  Naomi identified receiving primary support from the close relationships of her fiancé, 
godmother and mother.  
Naomi and Caroline shared the experience of feeling supported by the encouragement of 
a “motherly” figure.  Caroline talked about how her mother was affirming of the challenges she 
faced during her pregnancy, stating “I would tell her …’I totally forgot about this’, and she 
would either tell me about a time that happened to her, or she would give me something 
relatable. I remember she would cheerlead me, “You are going to have this baby and you are 
going to be so happy when you have her”… She would always cheer me on, “Don’t worry you 
have one more month.”  In reference to other types of support Caroline received from her 
mother, she stated “But my mom …and family where all so supportive and they would 
constantly come in …and cook dinner, clean the house, unpack boxes and things like that 
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(moving into a new home). That was really very comforting. You have to have a support system 
I feel like, at least for me personally.  That is what helped me stay sane.”  
Naomi’s mother lives far away and she talked about the importance of her godmother as 
a major support person in her life. When asked about who she felt was the main person she 
looked to for support, she responded, “My Godmother was; she still is to this day… She has been 
very supportive. She supports to the point where she considers me a daughter to her …. The 
good thing about her is she went with me to find out what I was having (gender of baby) and she 
is going to go with me when I find out what I am having with this one, so it has been a big help.”  
When Naomi was asked to talk about who helped her make decisions about managing her 
ADHD, she stated, “I am going to say mostly me, and my godmother, and my mother.” 
Both women were in committed relationships and discussed the important role their 
significant other played during their pregnancies. Caroline described this relationship as an 
important resource. For example, she shared the importance of her husband’s support when she 
first brought her daughter home. “My family was here and my husband and everyone was very 
supportive, I mean I saw them turn around in ways I never imagined possible, and I was super 
grateful for that because that is what I think really kind of helped me get through what… was 
definitely a scary time for me.” She shared how her husband was supportive in ways that were at 
times difficult for her to process and articulate in her comment, “There is something to be said 
that as women we go through a lot. There is a lot that we don’t even know how to verbalize… 
and my husband, I know … in his own way he has done a lot too…”. 
 Naomi identified her fiancé as a prominent source of support of whom she can rely on.  
Her comments revealed that she felt very supported by him through his encouragement for her to 
exercise and eat healthily during her pregnancy: “He is helping me try and get in shape, which is 
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hard while you are pregnant, but I can understand he still wants me to be pregnant and loose the 
weight, which I can understand. When it comes to buying food he is very supportive with that 
too. He is very helpful with a lot of things especially when it comes to… [their child together].” 
Naomi openly discussed their communication challenges stated they argue, and at times lose 
their tempers.  Naomi seemed encouraged in her fiancé’s desire to avoid this conflict, stating “He 
is being pretty good… telling me [that’s] why he doesn’t want to argue and don’t like fighting 
because this is what happens [the escalation of their arguing]. So that is why I try not to fight 
with him as much as possible.” Naomi expressed ambivalence about her decision to try and 
avoid this conflict. An example of this is when she stated, “…but sometimes it’s hard for me to 
want to tell him certain things…I feel like I can only tell him … when he is about ready to drink 
(alcohol), which I hate to say that, but that is when I feel he is going to listen to me.”   
Although Caroline’s and Naomi’s perceptions of their needs from their significant others 
are different, they identified their primary support comes from the same roles: a significant other 
(husband, fiancé) and a “motherly” figure (mother, godmother).  Both women share specific 
expectations of their significant others were separate and different from those significant 
matriarchal figures identified as important during their pregnancy period. Although, the 
expectations for their significant others were different, Caroline was looking for help with 
household duties and Naomi talked about communication needs. The expectations they perceived 
for their respective “motherly” figures were similar, looking for encouragement and wisdom as 
they manage their households.  
Maternal Role. This theme is defined as “…the role, processes, and set of behaviors that 
evolve over time in response to maternal experiences and are associated with nurturing and 
caretaking behaviors in the context of the mother-infant/child relationship” (Gardner, 2014, p. 
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814). This seemed to be a primary source of motivation for both women as they made decisions 
about their health and healthcare.  
In response to what helped her decide to discontinue her medication Caroline stated,  
“The healthy pregnancy and having a healthy child was number one to me. So whatever I had to 
do, I would have done it and I tried to do it.” Naomi shared how spirituality is important to her 
personally and also important in the raising of her children “in the church” as she was. When 
asked what has been the most helpful for her during her pregnancy she stated, “Reaching out to 
God for help. That is what I can say really helped me out a whole lot. Like I said …I like going 
to church because I feel like I can talk about what is going on.”  Naomi also reiterates this theme 
when sharing some of the behaviors she would like to change, for example, “If I am not doing 
anything, I might take her to the park like I told her (infant) today, if it is still nice out when we 
get home, we will go to the store and then we will go to the park because I want her to start 
going to the park, I want her to be active…” 
This maternal role seems intuitive and a primary motivating factors for many of the 
priorities that Caroline and Naomi articulated. In addition, this perceived maternal role 
influenced behavior that impacted health decisions, whether it was about treatment options or 
daily living in these two interviewees.    
Quantitative: Thirty-three women consented to participate in the online survey. Three 
participants agreed to participate, but did not progress past the inclusion criteria required to 
proceed through the survey. Therefore, their results were excluded from further analysis.  Thirty 
participants met inclusion criteria for participation in the study and their results are discussed 
below. Questions that were further analyzed by primiparous or multiparous status of the 
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participants will be reported separately. 
Demographics 
 Although 30 women completed the survey, only 29 women completed all the optional 
demographic questions. Sixteen women reported their last pregnancy as their first (Primiparous; 
n=16). Therefore we concluded that those who denied that this was their first pregnancy were 
multiparous (n=14), since all of these women reported a pregnancy with delivery date in the past 
five years during the screening questions. 
Table 1: Demographics 
Demographics 
Question Answer Responses Percentage 
Ethnicity 
Hispanic or Latino 1 3% 
White 28 97% 
Age 
Median 31 years old N/A 
Range 24-40 years old N/A 
Marital 
Status: Upon 
Discovering 
Pregnant 
Married 22 76% 
Living with Partner (not married) 5 17% 
Single (not married or living with 
partner) 
2 7% 
Marital 
Status:  At 
Delivery 
Married 24 83% 
Living with Partner (not married) 5 17% 
Single (not married or living with 
partner) 
0 0% 
Education 
Completed 
High School 1 3% 
Some college 4 14% 
Vocational Training 1 3% 
Associates Degree 2 7% 
Bachelor’s Degree 14 48% 
Master’s Degree 6 21% 
Doctorate Degree 1 3% 
Employment 
Status During 
Pregnancy 
Employed 19 66% 
Unemployed 2 7% 
Homemaker 5 17% 
Student 4 14% 
Unable to work 2 7% 
Insurance Private Insurance 24 83% 
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Medicare/Medicaid 3 10% 
Tricare 1 3% 
Other 1 3% 
Was this your 
first 
pregnancy? 
Yes 16 53% 
No 14 47% 
 
Twenty- eight (97%) of the respondents identified their ethnicity as white and 3% (n=1) 
as Hispanic or Latino. No respondents reported their ethnicity as African American, Native or 
American Indian, Asian or Pacific Islander or other. When asked about education, no 
respondents reported completing anything less than a high school degree or professional degree. 
Respondents were asked about employment during their last pregnancy and given additional 
options not reported in the table above.  No respondents reported being military or retired. Also, 
the answer choice “Employed for wages” and “Self Employed” were combined and reported as 
“Employed”, also “Out of work and looking for work” and “Out of work and not currently 
looking for work” were combined and reported as “Unemployed”.  When asked about insurance, 
no respondents reported having Veteran’s Affairs insurance, Indian Health Service or No 
Insurance. None of the respondents reported a personality disorder and 31% (n= 9) reported 
never being diagnosed with any of the disorders listed.  
Questions About Coping 
Table 2: Diagnosis, Treatment and Co-Morbidities 
Diagnosis, Treatment and Co-Morbidities 
Question Answer Response % 
Age at time of 
ADHD Diagnosis 
7-13yr 6 21% 
14-18yr 7 25% 
19 or older 15 54% 
Co-Morbidities 
P=Primiparous 
M=Multiparous 
Answered “Yes” P (N=16) M (N=14) % 
Depression 11 6 59% 
Anxiety 7 7 48% 
Bipolar 0 1 3% 
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Eating Disorder 1 2 10% 
Psychotic Disorder 0 1 3% 
None 4 5 31% 
Did you take any 
prescription medications 
for ADHD at any time 
during your last pregnancy? 
Yes 6 
20% 
No 24 
80% 
The six respondents who answered “Yes” were asked the question below 
If you can 
remember the name(s) 
please list in the space 
provided. 
1. Adderall ER 
2. Vyvanse 
3. Adderall 
4. Zoloft 
 
When participants were asked if they had taken any prescribed medication during 
pregnancy, six of the women responded, “Yes”. However, when these women were asked to list 
the medications, two of them reported discontinuing any medication once they discovered they 
were pregnant. Of the remaining four responses, one woman reported taking Adderall, one 
reported Adderall Extended Release, one reported taking Vyvanse and one reported taking 
Zoloft.  
Table 3: Managing ADHD 
Managing ADHD 
Question Answer Response % 
When you first 
learned you were 
pregnant, how worried 
were you about 
managing your 
ADHD symptoms? 
Not at all 10 33% 
Somewhat 
worried 
7 23% 
Very worried 13 43% 
Which ADHD 
symptoms did you 
have the most 
difficulty managing 
during your last 
pregnancy? 
Inattention 21 72% 
Hyperactivity 1 3% 
Impulsivity 6 21% 
None 1 3% 
Who was the Mother, Sister, 3 10% 
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Most women reported being worried about ADHD symptoms and reported some type of 
difficulty managing their ADHD symptoms. The biggest influence for women was their spouse 
or significant other, but the second most common choice was none, which could suggest that this 
decision is a very personal. Of the 28 respondents, most women seemed to be satisfied with how 
their symptoms were managed.  
Table 4: Conversations with healthcare provider and impact of symptoms 
Conversations and Impact 
Question Answer Response % 
Before you 
became pregnant, did 
Yes 6 21% 
most influential in 
your decision of how 
to manage your 
ADHD symptoms 
during your 
pregnancy? 
or Grandmother 
Significant 
Other or Spouse 
13 45% 
Other Family 
Member 
1 3% 
Friend(s) 1 3% 
Spiritual or 
Community Group 
1 3% 
Healthcare 
Provider 
3 10% 
Other 1 3% 
None 6 21% 
Were you 
satisfied with how 
your ADHD 
symptoms were 
managed? 
Yes 16 57% 
No 12 43% 
Looking back 
on your last 
pregnancy would you 
do anything 
differently? 
Yes 13 45% 
No 16 55% 
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you ever discuss with 
a healthcare provider 
how to manage your 
ADHD? 
No 23 79% 
Did you ever 
start a conversation 
with your healthcare 
provider about how to 
manage your ADHD 
symptoms? 
Yes 10 33% 
No 20 67% 
Which part(s) 
of your life were 
affected by your 
ADHD symptoms 
during your last 
pregnancy, if any? 
(Check all that apply) 
Work 19 66% 
Home 24 83% 
Neither 3 10% 
Which 
relationships were 
affected by your 
ADHD symptoms, if 
any? (Check all that 
apply) 
Romantic 
Relationship(s) 
19 66% 
Close 
Friend(s) 
11 38% 
Family 17 59% 
Neither 7 24% 
 
The majority of women did not recall having a conversation about how to manage their 
ADHD during pregnancy prior to becoming pregnant, and were not likely to initiate a 
conversation with their healthcare provider about management options. 
Primiparous and Multiparous Women 
Ten questions from the survey related to coping were further analyzed based on whether 
the respondent was primiparous (first time mother; n=16) or multiparous (having more than one 
child, n=14).    
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 Figure 1: Prescribed Medications Taken During Pregnancy 
 
 
 
 
 
 
 
 
 
 
 Women who responded, “Yes” were asked a follow-up question about the particular 
medications they took during their pregnancy. The responses listed were: Adderall Extended 
Release, Vyvanse, Adderall and Zoloft. Of the six women who responded “Yes”, two of the 
women indicated in the follow-up question they stopped their medication once they discovered 
they were pregnant; therefore their responses were not reported. 
Overall, 43% (n=13) reported, “Yes” and 57% (n=17) reported “No” to experiencing 
anxiety or depression symptoms. Of those who expressed experiencing anxiety or depressive 
symptoms 50% (n=7) were multiparous and 37% or N=6 were primiparous.  Women who 
responded, “Yes” were then asked, “Did you discuss these symptoms with a health provider? 
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Figure 2 : Anxiety or Depression Symptoms Experienced 
 
 
 
 
 
 
 
 
 
 
 
 
Of those who reported, “Yes” (n=13) to experiencing anxiety or depressive symptoms 
62% (n=8) of women acknowledged that they shared with their provider about these symptoms. 
Further analysis revealed, 62% (n=5) were primiparous and 38% (n=3) were multiparous. 
Primiparous mothers were more likely to discuss their symptoms with their provider. 
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Figure 3: Discussed these symptoms with a provider 
 
 
 
 
 
 
 
 
 
 
 
When asked if they were ever diagnosed with postpartum depression or baby blues, 20% 
(n=6) reported “Yes” and 80% (n=24) reported “No”. Of those diagnosed with Postpartum 
Depression 25% (n=4) were primiparous and 14% (n=2) were multiparous. 
Overall, 20% (n=6) reported gaining 0-25 pounds, 57% (n=17) reported gaining 26-50 
pounds, and 23% (n=7) reported gaining more than 50 pounds.   The majority of primiparous and 
multiparous mothers gained 26-50 pounds; however, more primiparous mothers gained 51+ 
pounds when compared to multiparous mothers.  
 In the next question women were asked whether or not they experienced financial, 
emotional, spiritual and physical support needs, and if so, the degree to which these needs were 
met. 
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Table 5: Support Needs 
Need Primiparous 
Yes 
Multiparous 
Yes 
Primiparous 
No 
Multiparous 
No 
Emotional 100% (n=16) 71% (n=10) 0% (n=0) 29% (n=4) 
Physical 44% (n=7) 21% (n=3) 56% (n=9) 79% (n=11) 
Financial 50% (n=8) 50% (n=8) 29% (n=4) 71% (n=10) 
Spiritual 60% (n=9) 43% (n=6) 40% (n=6) 57% (n=8) 
* Spiritual support only had 29 responses where the other forms of support had 30. 
Primiparous mothers reported more having more needs than multiparous mothers, given 
50% or more of primiparous mothers reported having emotional, physical and spiritual needs. 
The biggest need for primiparous mothers was emotional support with 100% of mothers 
expressing this need. Emotional support was also the biggest need for multiparous mothers. 71%  
(n=10) reported this as a need. Primiparous women reported spiritual support as their second 
highest reported need at 60% (n=9), whereas multiparous women reported financial support as 
their second highest at 50% (n=6).  
Although most multiparous and primiparous women reported having emotional support 
needs, most often this need was mostly or completely met. Primiparous women reported their 
emotional need was met, “only a little” (6% [n=1]) of the time, “mostly” met (81% [n=13]) of 
the time and “completely” met (13% [n=2]) of the time. Multiparous women reported their 
emotional need was met, “only a little” (30% [n=3]) of the time, “mostly” met (40% [n=4]) of 
the time and “completely” met (30% [n=3]) of the time. 
Interestingly, women who have experienced more than one pregnancy reported having 
had provider-led conversations about treatment options twice as many times as first time 
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mothers.  However, most of the respondents, despite their pregnancy experience, primiparous 
88% (n=14) and multiparous 71% (n=10), reported never having a discussion with their provider 
about treatment options. 
Figure 4: Treatment for ADHD during Pregnancy Discussed 
 
 
 
 
 
 
 
 
 
 
Overall women had concerns about how their ADHD symptoms would be managed with 
67% (n=20) reporting “Yes” and 33% (n=10) reporting “No”.  A higher proportion of first time 
mothers, 75% (n=12) reported concerns when compared to 57% (n=8) of experienced mothers. 
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Figure 5: Concern about management of ADHD symptoms 
 
 
 
 
 
 
 
 
 
 
 
Overall, 60% (n=12) of those women who reported having concerns shared them with 
their provider. Of those who expressed concern, primiparous n=9 and multiparous n=3, first time 
mothers were the most unsatisfied (57% or n=7) with how their provider addressed their 
concerns in comparison of those experienced mothers who reported being unsatisfied at 12% 
(n=1). Experienced mothers were twice as likely not to share their concerns, 63% (n=5), when 
compared to first time mothers, 25% (n=3). 
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Figure 6: Satisfied with how your provider addressed your concerns 
 
 
 
 
 
 
 
 
 
 
 
The last three questions from the survey were free text and allowed for individual 
responses.  
1. It would be helpful to know what would have been helpful and/or what 
you weren’t satisfied with. 
2. Looking back on your last pregnancy would you do anything differently? 
3. Please share anything else you think is important about how you managed 
your ADHD symptoms during pregnancy? 
Eleven of the 29 participants responded to the free text questions. In the first question, 
seven of the responses weren’t satisfied with the information they received or would have like 
more information about the management options that were discussed with them.  Two 
Satisfied with how your provider addressed your concerns? 
 for those shared these concerns
No satisfaction
(Primiparous)
7
No satisfaction
(Multiparous)
1
Satisfaction
(Primiparous)
2
Satisfaction
(Multiparous)
2
Never
(Primiparous)
3
Never
(Multiparous)
5
 
52 
 
respondents felt that a provider more knowledgeable about ADHD in women would have been 
helpful. One respondent felt like more family support would have been helpful, and one 
respondent would have liked more medication education. In the second question, five women 
reported seeking out psychotherapy or counseling services. Three women would have sought out 
more emotional support and two women would have sought nutritional counseling. One 
respondent would have explored alternative treatment options and one respondent would have 
continued her ADHD medications. In the third question there were fourteen responses, seven of 
the respondents reported having executive functioning skills as important to them and two 
respondents reported having a supportive employer or significant other. Other resources reported 
among the other four respondents included, coffee, their maternal role, stress reduction activities 
and medication as being helpful to then during their pregnancy.  
This survey data provides a variety of information from 30 women about their ADHD 
diagnosis, management options, and coping experience. The responses from women who were 
first time mothers and those who experienced pregnancy before provided a comparison of 
experience.  
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CHAPTER 7: DISCUSSION 
 
The quantitative data, supplemented by the rich detail of the two interviews, provides 
preliminary information about the coping experiences for the women in this study. These 
different data sources strengthen the discussion of the experience of women coping with ADHD 
during pregnancy. The information gained from the study is interpreted within the context of the 
study aims and the CODE framework. 
The interviewees presented with apparent differences and similarities. The similarities 
included:  ADHD diagnosis in childhood or adolescence, long history of managing their ADHD 
at transitional points in their lives, use of stimulant medication, discontinuation of medication 
upon discovery of pregnancy, close relationship with mother or mother-figure, and utilization of 
this support differently than the support from significant other. The differences included: 
socioeconomic status, co-morbidity of mental illness, and the experience of a second pregnancy. 
The survey participants shared feelings of worry about managing symptoms early in their 
pregnancy, identified emotional support needs, lack of conversations about ADHD symptom 
management with their provider, the impact of their symptoms on their home life, and their 
struggle with managing symptoms of inattention. Analysis of the demographics revealed that the 
majority of participants were married, white, with private insurance and educated with at least a 
4-year degree; these demographics are usually associated with a population that has more 
resources. 
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Identified Multi-contextual Factors. The multi-contextual factors that influenced the 
process of coping included socioeconomic security, relationship stability, co-morbidities, and the 
quality and variety of social support. Contextual factors were identified as an absence of 
something viewed as necessary, or the presence of something very helpful.  For example, the 
lack of a car was a significant stressor that required additional planning and organization, and 
placed further demands on the relationship.  The requirement of the work environment and 
ability to meet those demands without medication influenced one woman’s decision-making 
about the timing of her pregnancy, viewing less functionality as a potential threat to her job.   
The information from both quantitative and qualitative sources support the importance of 
multi-contextual factors as facilitators for or barriers to the coping process. This seems 
particularly relevant during the preference construction phase where the women are interpreting 
their choices and weighing the risk of each one amongst multi-contextual factors and 
circumstances.  Recognition of the positive and negative contributions of contextual factors 
offers opportunities for health care providers to assist women with decision-making about health 
care choices.  
Perceptions of Coping.  Both interviewees and survey respondents identified challenges 
to coping they faced during pregnancy. Common challenges for these women were staying 
organized, time and stress management, overcoming self- doubt and negative thoughts. Despite 
these challenges, the majority of women identified satisfaction with their ability to manage 
ADHD symptoms during this time.  Interestingly, the way in which women assessed their ability 
to cope was not through their strengths, but in what they identified as a weakness.  One 
interviewee revealed she viewed her inability to manage her symptoms of impulsivity and lack of 
motivation as a weakness. She identified needing medication to cope with this. The other 
55 
 
interviewee identified how she struggled with her performance at work. This was not typical in 
her experience and it had a negative impact on her self-esteem. However, upon reflection, she 
views her ability to persevere through the challenging time as an accomplishment. The women’s 
perceptions of their coping, and the barriers to and facilitators for their coping, yields important 
information to assist with decision-making should they have subsequent pregnancies.  
Emotional and cognitive processes in decision making. The emotional and cognitive 
processes necessary for healthcare decision-making are important as women assess their health 
risks and evaluate their degree of control over the situation. A major factor in this process is the 
woman’s knowledge of health care choices.  Both interview participants stated they did not have 
any prior knowledge of management options for ADHD outside of medication.  Interestingly, 
when women reported concerns about management, it was first time mothers who were more 
likely to express these concerns with their healthcare providers.  The data suggests neither 
interviewees nor survey participants had any discussion about alternative treatment options with 
their healthcare provider.  The interviewees seemed to have an “unquestioned” acceptance when 
they heard recommendations to discontinue their medication. The survey participants suggested a 
similar attitude in the free-text comments, asking for more support and additional resources, such 
as psychotherapy.  Additionally, the interviewees and majority of women surveyed reported not 
having any conversations pre-pregnancy with their healthcare providers about recommendations 
to discontinue medication. The data suggests the choices for how to manage ADHD symptoms 
did not occur through a patient-centered decision-making process and yet, a majority of women 
reported feeling satisfied with how their ADHD was managed.   
From the experiences reported by these women, the important of role of the healthcare 
provider is emphasized as the central access point for information about management and care of 
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ADHD during pregnancy. This appears to be a significant opportunity for psychiatric and 
obstetric providers to bridge this gap in knowledge. More specifically, psychiatric healthcare 
providers could ensure pre-conception conversations are occurring with women who have 
ADHD about management of their symptoms when they become pregnant and obstetric 
healthcare providers could “check in” with women about how they are coping with their ADHD 
symptoms and provide additional support or treatment as needed.  
Identification of sources of social and emotional support during pregnancy. 
Influential sources of support, both socially and emotionally, were identified through primary 
support relationships. Both quantitative and qualitative data acknowledged immediate family 
members and significant other or spouse, as key individuals on whom they relied for support. In 
particular, the interviewees shared many experiences in which their primary supports were 
instrumental with assisting them through successful negotiation of challenging times. This was 
supported in the data from survey participants.  
Provider specific influences.  The healthcare provider was considered the access point 
of information for management options for symptoms of ADHD. This data suggests there are 
additional areas in which provider knowledge can be helpful patient-centered decision-making. 
These areas include provider awareness of the role of primary support systems and recognition of 
the influence of contextual factors on the process of coping. Anticipatory guidance can be 
strengthened with a broad understanding of factors that influence coping as women explore this 
health threat and consider their choices.  
Application of Code framework. The initial phase of the health threat/contemplation of 
risk indicated that overall, women voiced concern about ADHD but not to their healthcare 
provider. However, when they had concerns about anxiety and depression they did discuss that 
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with their healthcare provider. The survey did not ask specifically about health threat so the 
survey participants response are not known.  However, further exploration during one interview 
revealed she did perceive as a health threat that might impact her ability to maintain a high level 
performance at work. In phase two, the discussion of choice, revealed the women reported 
discussion about choices for healthcare decision making with their healthcare provider.  The data 
supports the desire for choices and specific suggestions, which are supported by the evidence 
within the free text data and in both interviews. Moving forward, during a subsequent pregnancy 
several women indicated they would ask for different management options. The quantitative data 
reveals most women were concerned about managing ADHD symptoms, but when asked if 
satisfied about how their healthcare provider managed concern, 67% reportedly had concerns.  
Of those, 80% indicated they never got their concern addressed-whether or not the provider 
failed to address that satisfactorily or they never raised their concern specifically. For the 
preference construction phase, given there was no discussion of choice with providers, there 
seems like a lack of awareness of choice among the women.  The influencing contextual factors 
identified earlier suggest ranges of choices are needed when managing ADHD symptoms while 
pregnant.  Survey participants indicated the biggest influence in their decision-making was their 
spouse or significant other the second most frequent response was no one was used to assist in 
decision making, indicating they made healthcare choices alone. Although survey participants 
were not specifically asked about resources they were asked about their physical, emotional and 
social needs the women in the survey reported these needs were mostly met, which may indicate 
they had additional resources available to them; thereby, influencing their decision making 
choices.  There is insufficient data to further explore the process of decision-making, the key 
activity and preference construction, as the range of choices that might prompt decision-making 
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remained unknown to these women. As the women settled on a decision, the majority of women 
discontinued their stimulant medication once they became aware of their pregnancy. There is no 
data to indicate how they came to that decision.  Of all the study participants, only 3 (N=30) 
women indicated they continued stimulant medication during pregnancy. The majority of 
participants indicated they would engage in additional decision making with subsequent 
pregnancies. When asked specifically about future decision-making, women indicated they 
would make other decisions, such as initiating discussions with healthcare provider or seeking 
psychotherapy. The final phase, consolidation, requires the women to reflect on the 
consequences of their decision-making as it relates to their perceptions of a health threat.  
Overall, more women reported satisfaction with their decision making as it related to their 
coping. Despite expressing a desire for different options, 57% were satisfied with how they 
managed their ADHD symptoms and 45% reported they would have done something differently. 
The code framework deconstructed the coping process in a manner useful for a greater 
understanding of the experiences of these women who were managing ADHD symptoms while 
pregnant.   
Limitations 
The study has several limitations.  The sample is small and self-selected. The inclusion 
criteria for the survey participants was not able to be validated. This small sample does not allow 
our findings to be generalizable to any population. Also due to the homogenous sample the 
results cannot be generalizable even if statistical significance was achieved. 
Recommendations for Further Study 
The information gained from this study may be used in the development of a group 
therapy curriculum focused on the themes identified in the data and evidenced-based literature. 
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The curriculum for this treatment group would be modeled after the CODE framework and 
include the four phases of deliberation and consolidation. Women would be allowed to enter the 
group at any phase as this framework allows for a transcendent process, thus women would be 
able to learn from each other’s experiences. The group would include psycho-education about 
ADHD, symptoms, medication, and alternative management strategies during pregnancy. It 
would also include process discussion related to the women’s experiences of coping with ADHD 
symptoms during pregnancy. It is anticipated the outcomes of this intervention might include: an 
increased sense of empowerment related to decision making about healthcare choices, increased 
knowledge of management options for ADHD, and an experience of social support.  
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CHAPTER 8: CONCLUSION 
 
The literature supports negative outcomes associated with untreated ADHD symptoms in 
adults (Fredriksen et al., 2014).  Women with ADHD are more vulnerable to the development of 
anxiety and depression than women without an ADHD diagnosis (Quinn, 2008).  Furthermore, 
the literature has linked perinatal depression with negative outcomes in the unborn child 
(Grigoriadis et al., 2013).  Although there is no evidence to support a direct link between 
unmanaged ADHD in women who become pregnant, and negative outcomes; there is evidence to 
support the value of patient-centered care and the importance of shared decision-making to better 
understand this population.  Given the increase in prescription rates for stimulants used to treat 
women with ADHD of childbearing age, more women will be faced with the decision to 
discontinue stimulant medication and determine new strategies for management of their ADHD 
when they become pregnant (Armstrong, 2014).  Therefore, it is imperative that clinicians 
engage effectively in patient-centered care and assist with healthcare decision-making in 
situations in which a health threat exists. 
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APPENDIX 1: CODE Framework 
 
Reprinted with permission from the author (Witt et al., 2012) 
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APPENDIX 2: Application of CODE 
 
   
 
See Figure 2. (Witt et al., 2014) 
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APPENDIX 3: Announcement to Providers 
 
 
 
Dear Providers, 
Do you know or treat a woman with Attention Deficit Hyperactivity Disorder (ADHD) 
who is between the ages 18-40 and has delivered a baby in the last 5 years? 
I am asking for your help identifying women with ADHD between the age of 18-40 and 
has delivered a baby in the last 5 years, and may be eligible to participate in a survey about their 
coping experience during pregnancy. The aim of the study is to gather information about 
women’s perspective coping with ADHD during pregnancy. 
Eligibility Requirements: 
Women diagnosed with ADHD 
Between the ages 18-40 
Delivered a baby in the last 5 years 
Survey Details: 
Participants can enter a drawing for a $25.00 Target gift card  
21-23 questions about their experience and 8 demographic questions. 
Approximately 15-20 minutes to complete 
Survey Qualtrics to ensure security- and NO identifiable information is asked. 
Ways to share information about the study: 
Our Website: www.adhdandcoping.com 
Recruitment Flier (attached) – To hang up or distribute 
Create a new email and copy the survey link below: 
Click here to take the survey! 
The Institutional Review Board at the University of North Carolina at Chapel Hill 
approved this .study IRB # 14-2989. For more information visit our website 
http://www.adhdandcoping.com/ or contact the. Principal Investigator: Jessica Sparrow 
(jgsparro@email.unc.edu)  
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APPENDIX 4: Consent 
 
University of North Carolina at Chapel Hill Information about a Research Study 
IRB Study # 14-2989 
 
Title of Study: Coping with Attention Deficit Hyperactivity Disorder During Pregnancy 
 
Principal Investigator: Jessica Sparrow 
Principal Investigator Department: School of Nursing  
Principal Investigator Phone number: xxx-xxx-xxxx  
Principal Investigator Email Address:jgsparro@email.unc.edu 
                                                                
What are some general things you should know about research studies? 
You are being asked to take part in a research study. To join the study is voluntary. 
You may refuse to join, or you may withdraw your consent to be in the study, for any reason, 
without penalty. 
Research studies are designed to obtain new knowledge. This new information may help people 
in the future.  You may not receive any direct benefit from being in the research study. There 
also may be risks to being in research studies. Details about this study are discussed below. It is 
important that you understand this information so that you can make an informed choice about 
being in this research study. You will be given a copy of this consent form. You should ask the 
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researchers named above, or staff members who may assist them, any questions you have about 
this study at any time. 
What is the purpose of this study? 
There is limited literature to describe how ADHD manifests during pregnancy, nor are there 
standard guidelines to address management of ADHD when a woman becomes pregnant. 
Pregnant women are often faced with choices for how to manage their ADHD symptoms if they 
stop medication during pregnancy. There exists little in the literature describing a woman's 
coping process during this time. These interviews are intended to provide preliminary 
information that will assist with the development of a pilot study to gain more information about 
the management of ADHD symptoms during pregnancy.  
The purpose of this research study is to obtain information about how women cope with their 
ADHD symptoms during their pregnancy.        
You are being asked to be in the study because you are a woman diagnosed with ADHD, between 
the ages of 18-40 and delivered a baby less than 5 years ago.                
Are there any reasons you should not be in this study? 
You should not be in this study if talking about your coping experience with ADHD during your 
pregnancy would make you feel uncomfortable or distressed.          
How many people will take part in this study? 
There will be up to three women who will participant in this study. 
How long will your part in this study last? 
Participation in this study will include one interview, which will last approximately 60-90 minutes 
with the option of a follow up interview within 14 days, if you choose.  
What will happen if you take part in the study? 
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Overall Design: 
You will be called by Carolina Outreach to schedule an interview   
During the interview with Ms. Sparrow you will be assigned a pseudonym. You will be asked a 
series of questions about your ADHD experience and decision-making during your pregnancy. 
Though your participation is required for you to be involved in this research study, it is not 
required for you to answer each question; you may skip a question, or stop the interview at any 
time with no repercussions.  At the end of the research study you will be given the opportunity to 
schedule a follow up interview within 14 days from the date of the interview. 
What are the possible benefits from being in this study? 
You will not benefit personally from being in this study. The information gained from the study 
will be used to assist with the development of a pilot study in which more women will be 
interviewed to share their experiences. 
What are the possible risks or discomforts involved from being in this study? 
There are no known risks to this study. However, it is possible you may experience emotional 
discomfort as you describe your experiences of coping with your ADHD symptoms during 
pregnancy, if those experiences were negative. If this were to happen you should report this to 
Ms. Sparrow. 
What if we learn about new findings or information during the study? 
You will be given any new information gained during the course of the study that might affect 
your willingness to continue your participation. 
How will your privacy be protected? 
The following are confidentiality practices that will be implemented to increase the level of 
confidentiality and maintained throughout this study: The principal investigator (Jessica 
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Sparrow) is the only person who will be knowledgeable of your identifiable information  No 
other person related to this study will see any identifying information and it will never be 
transcribed or recorded. You will be assigned an alias and your real name will never be disclosed 
Data collection instruments will not contain any identifying information 
You will not be identified in any report or publication about this study and no voluntary 
disclosures will be made. A digital voice recorder will be used to record the interview, and after 
the interview, your audio recording will be moved to password-protected computer and saved in 
a unique password-protected file. The information will be digitally transcribed by Ms. Sparrow 
and also saved to a password-protected computer in a password- protected file. Ms. Sparrow will 
be the only person to have access to these transcribed documents. During transcriptions, all 
identifying names, titles, and characteristics will be omitted or substituted for fictitious ones. The 
recordings will be deleted after the transcription process is complete, no later than three days 
after the interview. References or quotations from the transcripts may be used as content in the 
final paper for this project, but these, too, will contain no identifying information. Participants 
will not be identified in any report or publication about this study. Although every effort will be 
made to keep research records private, there may be times when federal or state law requires the 
disclosure of such records, including personal information.  This is very unlikely, but if 
disclosure is ever required, UNC-Chapel Hill will take steps allowable by law to protect the 
privacy of personal information.  In some cases, your information in this research study could be 
reviewed by representatives of the University, research sponsors, or government agencies (for 
example, the FDA) for purposes such as quality control or safety. 
What if you want to stop before your part in the study is complete? 
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You can withdraw from this study at any time, without penalty. Ms. Sparrow also has the right to 
stop your participation at any time. This could be because you have had an unexpected reaction, 
or have failed to follow instructions, or because the entire study has been stopped. 
Will you receive anything for being in this study? 
You will be receiving a $40.00 Target gift card for taking part in this study. 
Will it cost you anything to be in this study? 
If you enroll in this study, you might have costs, which include: 
Travel expenses and childcare that incur because of your participation in this study.  
What if you have questions about this study? 
You have the right to ask, and have answered, any questions you may have about this research. If 
you have questions about the study (including payments), complaints, concerns, or if a research-
related injury occurs, you should contact Ms. Sparrow, listed on the first page of this form. 
What if you have questions about your rights as a research participant? 
A committee that works to protect your rights and welfare reviews all research on human 
volunteers. If you have questions or concerns about your rights as a research subject, or if you 
would like to obtain information or offer input, you may contact the Institutional Review Board 
at 919-966-3113. 
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APPENDIX 5: Semi-Structured Interview 
 
1. How old were you at your last pregnancy? 
2. Did you work or were you a student during your last pregnancy? 
3. What race or ethnicity would you identify yourself as? 
4. Tell me about the support you had at home? (explore who she was in a 
relationship with and who she lived with) 
5. When were you diagnosed with ADHD? 
6. Prior to becoming pregnant how was your ADHD managed/treated? 
7. Did you have to make a choice about continuing or discontinuing your stimulant 
medication when you learned you were pregnant? 
8. If answered yes to #7: How did you feel about making the choice to continue or 
discontinue your stimulant medication?  
9. What was your understanding of how your ADHD would be managed once you 
become pregnant?  
10. Tell me about what your ADHD symptoms look like to you? 
11. Did you feel like your symptoms were different during your pregnancy? 
12. Did you feel like your symptoms were well managed with stimulant medication 
before you became pregnant?    
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13. Which part of your life (Work, Home, Social, Spiritual) did you believe would be 
affected the most because of your ADHD symptoms during your pregnancy?  
14. When you began to think about how to manage your ADHD during pregnancy, 
were you aware of any risks associated with not managing/treating your ADHD 
symptoms?  
15. Were you aware of any other management or treatment options for your ADHD 
symptoms, other than stimulant medication, that were safe to use during 
pregnancy? 
16. Was there anything that you can recall that would alert to you that your ADHD 
wasn’t being managed?  
17. Looking back on your pregnancy did you feel like you were able to manage these 
symptoms? If so, how? 
18. Did you have any physical, emotional, spiritual needs? If yes, describe how well 
these needs were met.   
19. What was the most influential factor in your decision to manage or treat your 
symptoms  (x,y,z treatment) during your (first, second, third) trimester?  
20. As you think back, would you do anything differently? If so, what? 
21. What factors helped you make a decision that you were at peace with?  
22. Is there anything else you would like to share with me that will help me 
understand your experience of coping with ADHD during pregnancy?  
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APPENDIX 6: Survey Questions 
 
*Bolded headings are only included for clarity and would not be included on the survey. 
  
Screener Questions: 
1. Have you been diagnosed by a healthcare provider with Attention Deficit Hyperactivity 
Disorder (ADHD)? 
a. Yes 
b. No 
2. Have you delivered a baby in the last 5 years? 
a. Yes 
b. No 
3. What was the date of your last delivery? (mm/dd/yyyy) 
 
4. What is your current age? (1-9999 numerical value) 
 
Survey Questions: 
Instructions: Please answer the following questions based on what you experienced 
during your most recent pregnancy. 
1) Was this your first delivery? 
a) Yes 
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b) No 
 
2) Did you take any prescription medications for ADHD at any time during your last 
pregnancy? 
a) Yes  
i) If you can remember the name please list in the space provided (Free 
text) 
b) No 
 
3) During your last pregnancy, did you experience anxiety or depressive symptoms 
that you or those closest to you were concerned about? 
a) Yes  
i) Did you discuss these symptoms with a healthcare provider? 
(1) Yes 
(2) No 
b) No 
 
4) Following your last delivery, were you ever diagnosed with Post-partum 
Depression or Baby Blues? 
a) Yes 
b) No 
5)  How much weight did you gain during your last pregnancy? 
a) 0-25 pounds 
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b) 26-50 pounds 
c) More than 50 pounds 
 
 For each type of support listed below, please indicate in the first column whether you 
needed this type of support during your last pregnancy. 
If you answer yes to needing support, then indicate in the second column, the degree to 
which your need was met.  
Type of 
Support 
Did you 
need this 
type of 
support? 
To what extent was this need met? 
ONLY IF “YES” ANSWERED 
 Yes No Not at all 
Only a 
little 
Mostly Completely 
Emotional 
Support 
      
Physical 
Support 
      
Financial 
Support 
      
Spir
itual 
Support 
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6) During your pregnancy, which of the following ADHD symptoms did you have 
the most difficulty managing or coping with, if any? 
a) Inattention (carelessness, easily distracted, poor motivation, 
procrastination) 
b) Hyperactivity (fidget when sitting for long periods, difficulty relaxing or 
winding down during time alone, talking too much in social settings) 
c) Impulsivity (difficulty waiting your turn, often interrupt others when or 
finish someone’s sentences) 
d) None 
 
7) When you first learned you were pregnant how worried were you about managing 
your ADHD symptoms during the pregnancy?  
a) Not at all 
b) Somewhat worried 
c) Very worried 
8) Which part(s) of your life were affected by your ADHD symptoms during your 
last pregnancy, if any?  Check all that apply 
 Work 
 Home 
 Neither 
9) Which relationships were affected by your ADHD symptoms during your last 
pregnancy, if any? Check all that apply 
 Romantic Relationship(s) 
 Close friend(s) 
 Family 
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 Neither 
 
10)  Did a healthcare provider ever discuss with you any treatment options besides 
medicine that could be helpful in managing your ADHD symptoms during your pregnancy? 
a) Yes 
b) No 
 
11)  Did you ever have concerns about how your ADHD symptoms would be 
managed during your last pregnancy? 
a) Yes 
i) If you shared these concerns with a healthcare provider were you 
satisfied with how they were addressed? 
(1) Yes 
(2) No 
(3) Never shared my concerns 
b) No 
12)  Before you became pregnant, did you ever discuss with a healthcare provider 
how to manage your ADHD symptoms during your pregnancy? 
a) Yes 
b) No  
13)  During your pregnancy did you ever discuss with a healthcare provider how to 
manage your ADHD symptoms during your pregnancy? 
a) Yes 
b) No  
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14)  Who was the most influential in your decision of how to manage your ADHD 
symptoms during your pregnancy? 
a) Mother, Sister or Grandmother 
b) Significant Other or Spouse 
c) Other Family Member 
d) Friend(s) 
e) Spiritual or Community Group 
f) Healthcare Provider 
g) Other ____ 
h) None 
 
15)  Were you satisfied with how your symptoms were managed during your last 
pregnancy? 
a) Yes 
b) No 
i) Can you explain what you weren’t satisfied with? (Free Text) 
16)  Looking back on your last pregnancy would you do anything differently? 
a) Yes 
i) Please explain what you would do differently (Free Text) 
b) No 
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17)  Please share anything else you think is important about how you managed 
ADHD symptoms during your pregnancy. (Free Text) 
Demographics:  
1)  Please specify your ethnicity. Mark all that apply 
 White 
 Hispanic or Latino 
 Black or African American 
 Native American or American Indian 
 Asian / Pacific Islander 
 Other ______ 
 
2) When you found out you were pregnant what was your relationship status? 
a) Married 
b) Living with a partner (but not married) 
c) Single (not married or living with partner) 
 
3)  At the time of your last delivery what was your relationship status? 
a) Married 
b) Living with a partner (but not married) 
c) Single (not married or living with partner) 
 
4)  What is the highest degree or level of school you have completed?  
a) No schooling completed 
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b) Nursery school to 8th grade 
c) Some high school, no diploma 
d) High school graduate, diploma or the equivalent (for example: GED) 
e) Some college credit, no degree 
f) Trade/technical/vocational training 
g) Associate degree 
h) Bachelor’s degree 
i) Master’s degree 
j) Professional degree 
k) Doctorate degree 
 
5)  How old were you when you received your ADHD diagnosis? 
a) 7-13 
b) 14-18 
c) 19 or older 
6)  What was your employment status during your last pregnancy? Check all that 
apply 
 Employed for wages 
 Self-employed 
 Out of work and looking for work 
 Out of work but not currently looking for work 
 A homemaker 
 A student 
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 Military 
 Retired 
 Unable to work 
 
7)  Have you ever been diagnosed with the following? Check all that apply 
 Depression 
 Anxiety 
 Substance Abuse 
 Bipolar, Eating Disorder 
 Psychotic Disorder 
 Personality Disorder 
 None 
 
8)  During your last pregnancy, what type of healthcare coverage did you have, if 
any?  
If you had different types of insurance, please indicate the one you had for most of 
your pregnancy. 
a) Insurance through a current or former employer 
b) Insurance purchased directly through an individual insurance company 
c) Medicare and/or Medicaid 
d) Tricare or other military health insurer 
e) Veterans Affair (VA) or VA healthcare 
f) Indian Health Service 
g) Other 
h) I had no insurance 
 
 
80 
 
 
 
APPENDIX 7: Qualitative Analysis 
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APPENDIX 8: Code Manual  
The code manual serves to provide a code name, definition and description for coding 
during data analysis. 
 Each code has a: 
Label= the code name 
The definition of what the code is 
A description of how to know when and what warrants being coded.  
 
The Process- 4 phases of deliberation 
Health Threat 
Label- P1 (Phase 1) 
Definition- Presentation of health threat or disclosure of risk. 
Description- Contemplation of risk associated with threat in context of identity, timeline, 
cause, consequences and what can be controlled. 
Discussion of Choice 
Label- P2 (Phase 2) 
Definition- Introduction of choices where internal/external resources are described and 
discussed. 
Description- The case weighs the risk/benefit, while also considering the emotions 
experienced with each choice or resource. 
Preference Construction 
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Label- P3 (Phase 3) 
Definition- Choices are interpreted by the case. 
Description- Process of formulating a decision, heavily influenced by contextual factors 
and circumstances. 
The Decision 
Label- P4 (Phase 4) 
Definition- A coping strategy is selected, either problem- or emotionally-focused 
Description- Choices have been weighed, interpreted and the preferred choice is made. 
Doesn’t have to be a treatment decision, can be deferred to another person or avoided all 
together.  
Consolidation 
Label- P5 (Phase 5) 
Definition- Deliberation beyond when the actual decision was made. 
Description- A coping mechanism designed to defend a decision from regret in the 
future. 
The Unit of Analysis- Coping 
Pre-pregnancy factors 
Label- Pre-Pregnancy 
Definition- Pre-pregnancy contextual factors (Beliefs, Values, Goals, Past Experience, 
Social Support) and circumstances having influence on the case’s coping. 
Description- Broad range of factors existing before the case is pregnant that influence her 
decision-making at present.  
Motivational Factors 
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Label- Value 
Definition- Factors the case values or views as a personal priority.  
Description- Motivator’s for the case, which could be a range of factors: health, financial 
 security, family support, physical affection, words of affirmation, etc.  
Emotional Experiences 
Label- Feeling 
Definition- Any emotion expressed or deduced based on verbalization or behavior during 
the interview.  
Description- Happy, Worry, Anger, Fear 
Needs 
Label- Need 
Definition- Consciously unmet needs that detract from case’s ability to deal with day-to-
day situations or events. 
Description- Taken from Maslow’s (Citation) hierarchy of needs: 
 Biological and Physiological needs - air, food, drink, shelter, warmth, sex, sleep. 
 Safety needs - protection from elements, security, order, law, stability, freedom 
from fear. 
 Love and Belongingness needs - friendship, intimacy, affection and love, - from 
work group, family, friends, romantic relationships. 
 Esteem needs - achievement, mastery, independence, status, dominance, prestige, 
self-respect, and respect from others. 
 Self-Actualization needs - realizing personal potential, self-fulfillment, seeking 
personal growth and peak experiences. 
 
 
 
 
84 
 
 
 
APPENDIX 9: Naomi CODE Application and Summary 
 
Code 
Application 
Support for code Explanation Notes: 
 
Phase 1-Health 
Threat  
“PI: Now when you first 
found out you were 
pregnant where you excited 
about it 
N: I was excited about it 
but I was also scared like 
how am I going to do this, 
this is my first child. It felt 
weird but going through it 
was difficult, I had support 
but then I had other people 
aggravating me about it and 
the whole situation.” Pg. 1 
 
“PI: Did you know that 
during your pregnancy you 
would have to stop 
medication 
N: No I did not know that.” 
Pg. 5 
 
 
Here she is facing two 
threats.  She states she 
didn’t know you had to 
come of medication 
(which she indicates 
has been helpful for 
her) and she faces the 
conflict (threat) of an 
unplanned pregnancy. 
 
Phase 2- 
Choices 
“PI: Did your provider ever 
talk about any treatment 
options other than 
medicine? 
N: The only medicine they 
gave me me was prenatal 
pills that was it that was all 
they gave me. ” Pg. 8 
 
“PI: Did you take anything 
just for a short amount of 
time 
N: Just the Latuda 
PI: Do you remember how 
From this statement 
you see that she didn't 
know/ explore any 
other options because 
of what the provider 
said.  Here the provider 
plays a significant role 
in the access of 
information 
Here the provider plays 
a significant role in the 
access of information… 
Caroline experiences this 
too with her OB/GYN 
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long you took Latuda  
N: Like 3-4 months 
PI: Do you remember why 
you prescribed the Latuda  
N: Mood stabilizer and to 
help me sleep better” Pg. 1 
Phase 3-Preface 
Construction 
“No, they made me go off 
of it….the doctor said you 
can’t be on ADD medicine 
while you are pregnant” Pg. 
13 
 From this statement 
you see that the 
provider’s knowledge 
is weighted it’s hard to 
grasp if she ever asked 
about other options or 
if there was more to 
this conversation based 
on the current 
transcript 
It would have been good 
to explore if she pushed 
for more information 
Phase 4- The 
Decision 
“PI: So you stopped your 
medications 
N: Yes  
PI: Did you know that 
during your pregnancy you 
would have to stop 
medication 
N: No I did not know that “ 
Pg. 4-5 
The decision was made 
automatically upon 
hearing she had to stop 
her medications.  
It would have been good 
to follow up with her 
about whether or not she 
explored other options.  
Phase 5- 
Consolidation: 
 
“What they could have put 
me on, even if it wasn’t that 
strong, but at least 
something to help control 
my ADHD and my 
impulses while I am 
pregnant 
PI: So it would have been 
helpful for someone to 
have actually talk to you 
about some options and try 
and manage it instead of 
just saying “Well there is 
nothing that we can do” 
N: Exactly” Pg. 16 
 
 You get a sense that 
she did struggle and 
perhaps would like to 
reevaluate her decision.  
At this point she is “in 
the throws” of being un-
medicated and 
pregnant…It would be 
interesting to see if her 
perspective changes 
once she has the baby. 
Need: 
$$ 
“PI: When you were 
talking about the fight with 
Taye, you said about 
having the money and 
possibly over drafting your 
Here she talks about 
over-drafting her 
account.  Talking about 
needing money for a 
basic need food- this is 
 
86 
 
account, would you say that 
you needed some financial 
support  
N: I would say I just 
wanted the money so we 
could have gone to the 
grocery store to buy some 
groceries  
PI: Did you need more 
money at that time? Maybe 
not at that time but do you 
feel like during your 
pregnancy money was tight  
N: Yes because we both did 
not have a job and I had to 
ask for money just about 
every other week. “ Pg.7 
a huge unmet need and 
significant stressor in 
caring for herself and 
her daughter. 
Need: 
Supportive 
Partner 
“PI: Ok Tayes. What about 
your emotions. Did you 
feel supported during 
pregnancy? 
N: It was hard to say 
because I was stressed out a 
lot mainly because of his 
daughter’s mother…. There 
would be a couple of times 
where if he got mad he 
would go over there and 
stay the weekend and I am 
like ok… what was going 
on the whole time you was 
over there and I would get 
frustrated. “ Pg. 7 
 
“but sometimes its hard for 
me to want to tell him 
certain …I feel like I can 
only tell him about it when 
he is about ready to drink, 
which I hate to say that, but 
that is when I feel he is 
going to listen to me and 
…when I talk to him when 
he is sober he might be ok 
with it just a tad, but if he is 
about to drink he is a whole 
It’s interesting 
that she projects her 
lack for support from 
her fiancé is because of 
his ex.  
 
The ex is 
clearly a significant 
player… but I think 
only because she has a 
difficult time saying… 
my fiancé’ needs to get 
it together.   
 
 
 
 
Her desire for a 
partner is so apparent 
through out this 
interview!  
 
She wants him 
to step up… and it 
seems like he is doing 
better this pregnancy 
than the last one… but 
they are about to have 
their circumstances 
Barriers to 
experiencing a 
supportive partner: 
1) Partner’s 
continued 
involvement with 
another woman 2) 
has a child with this 
person 3) history of 
mental illness 4) 
history of anger 
management 
problems 
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lot more lenient about 
it.”Pg. 14 
 
“…I am learning how to 
trust her now because 
knowing that he has a car 
he has no reason to be 
home late. When we didn’t 
have a car those days were 
scary because I would call 
him before catching the 
bus, because we knew 
exactly what time the bus 
would come at, so I would 
get scared if he wasn’t at 
the bus stop at the right 
time 
PI: Like for his safety or 
for fooling around 
N: I knew he wasn’t 
fooling around but I guess 
she figured that as long as 
he was over there he could 
make her spend the night, 
but he wouldn’t do 
anything with her because 
they had separate 
rooms.”Pg. 11 
 
“…One of the things I wish 
for at that time too is if he 
would miss his ride going 
home he would have called 
a cab and to make sure he 
had cab money just in case. 
That would have helped. 
Like if you know you are 
going to be late and you 
missed the bus take a cab 
home even if it cost 
money.” Pg. 11 
 
“He is helping me try and 
get in shape, which is hard 
while you are pregnant, but 
I can understand he still 
change with another 
baby. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
She finds 
support in his desire for 
her to loose weight… 
you see her 
perspective. I wonder if 
she would feel more 
supportive if he invited 
her for walks or 
watched the baby so 
she could go to the 
gym. 
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wants me to be pregnant 
and loose the weight, which 
I can understand. When it 
comes to buying food he is 
very supportive with that 
too. He is very helpful with 
a lot of things especially 
when it comes to her” pg. 8 
 
 
Need: 
Transportation 
“…That was one of the 
things I hated, but now that 
we have a car it is a whole 
lot easier, when he goes 
over there… he is not over 
there that long, when he 
didn’t have a car he would 
have to make sure he got 
on the bus at the right time 
and that was the scary part. 
I hated that because there 
would be nights where she 
would probably make him 
miss the bus just to talk to 
him, she would have a 
conversation with him to 
try and distract him so he 
would miss the bus and 
those nights I couldn’t take 
it because she would get 
mad at him if he was 
talking to me on the phone 
so yeah we had our battles 
during those times.”Pg. 7 
You see here 
during the first 
pregnancy they don’t 
have a car… which 
means the fiancé has an 
excuse to stay later at 
the ex’s house and 
therefore this is a 
stressor for Naomi, 
though she says its for 
safety… its apparent 
that she worries about 
infidelity too! 
Therefore during this 
pregnancy now that 
there is a car it really 
changes her stress level 
about her fiancé going 
over to the ex’s this 
one variable makes a 
world of difference for 
her! 
Its interesting 
how this one resource 
changes her 
circumstances and 
stress… imagine what 
things would be like if 
she had even more 
resources. 
 
Need: 
Personal Safety 
 
“…He was telling me and 
her that this was going to 
be the last time that he was 
going to be spending the 
weekend with her so he 
was coming home on 
Friday to get his clothes 
and then coming back on 
Sunday, which I was not 
happy with so we got into a 
fight and I told him to leave 
and he came back.. so the 
She doesn’t 
herself describe 
abuse… but she does 
tip toe around his anger 
issues and changes her 
behavior to control his 
anger 
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police told him to leave so 
he left and he came back to 
the house and that was the 
worst, because he came 
back and he was angry and 
he was doing pushups…I 
am not letting you go and 
my mother called the 
cops.” Pg. 6 
“N: The first time they sent 
him to the hospital was 
because he was tearing 
things up in the house and 
he was in the hospital for a 
month. Then he went to jail 
again because he had 
assaulted me.” Pg. 6 
 
“but sometimes its hard for 
me to want to tell him 
certain …I feel like I can 
only tell him about it when 
he is about ready to drink, 
which I hate to say that, but 
that is when I feel he is 
going to listen to me and 
…when I talk to him when 
he is sober he might be ok 
with it just a tad, but if he is 
about to drink he is a whole 
lot more lenient about 
it.”Pg. 14 
 
Need: 
ADHD 
symptom 
management 
 
PI: During this pregnancy, 
now you know more, where 
you as worried as how you 
would manage your ADHD 
N: I was so stressed I didn’t 
even know, and now it is 
like I feel like managing it, 
one thing I hate is the fact 
that sometimes I feel like I 
can’t focus like there are a 
lot of times I will get my 
impulses but I was proud of 
myself yesterday because I 
This need to 
“hold it together” is 
really a daily struggle 
for her.  Just showering 
herself or making sure 
she doesn’t impulsively 
spend money… which 
would impact her 
financial needs… 
ineffectively managing 
her symptoms has a 
significant impact on 
the level of her daily 
Further 
complicated with co-
morbid psychiatric 
illness 
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got money yesterday and I 
haven’t spent it yet, I was 
proud because I said I 
wasn’t going to spend it 
today I was going to spend 
it tomorrow, I am going to 
get what I really want to 
get. Usually my impulses 
would make me spend it 
automatically without even 
thinking about it. Another 
thing with dealing with her 
my focus too, is in the 
beginning, I am good with 
hygiene with me but not 
with her but I am trying to 
do better with that.”Pg. 9 
functioning 
Need: 
Healthy 
Lifestyle 
 
“PI: Looking ahead if you 
could do things differently 
with this pregnancy, would 
you do anything different 
like about how you 
managed your mental 
health? 
N: If I really could I would 
try and get out to walk 
more and try and walk 
every day and know I have 
no excuses on why I can’t 
walk because I know I can 
and maybe try to eat better 
too..” Pg. 15 
 
“…now ever since she has 
lost all this weight and she 
is giving me her clothes 
and I can’t get over the fact 
that she had lost all that 
weight because she is very 
motivated, she goes 
walking every day and she 
even tries to go to the gym 
too and that is why I try 
and get out to walk  too” 
Pg. 15 
She makes 
several comments 
throughout the 
interview about 
wanting to be active 
and the desire to lose 
weight.  
 
She wants to be 
motivated but she’s has 
difficulty putting this 
into action. She 
identifies the lack of 
ADHD medication as 
being a reason for her 
lack of motivation 
 
Feeling: “…I am hoping by the time Not feeling  
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Disprove
s of physical 
appearance 
 
I have my next child I can 
get back into shape because 
I don’t like how I am 
now…” Pg.10 
good about her weight 
seems to weigh heavy 
on her mind  
Value: 
Spirituality 
“PI: If you look as the 
spheres of your life: social, 
work (school), home life 
and spiritual, what of those 
four things do you think is 
most impacted by your 
ADHD symptoms when 
you are pregnant 
N: My spiritual. The reason 
I say that is because I try to 
go to church as much as I 
can but my brain is telling 
me to go to church Sunday 
but I don’t know if I am 
going to want to get up and 
that is what hurts because I 
am so spiritual and I want 
to go to church.” Pg. 14 
 
“I want to raise my kids in 
something I was raised in” 
Pg. 14 
 
“…reaching out to God for 
help. That is what I can say 
really helped me out a 
whole lot. Like I said, I like 
coming to therapy because 
I can talk about what is 
going on and I like going to 
church because I feel like I 
can talk about what is 
going on too” pg. 18 
 
“I am trying to get myself 
to go every Sunday but 
something always stops me 
and I don’t like that 
because I want to raise my 
kids in the religion …I 
need to start going to one 
because I want my 
She emphasizes 
her spirituality as 
something very 
important to her…  
 
We see how 
important this aspect of 
her life is… church is 
like therapy for her. 
However, it 
almost seems like she 
interpreted the question 
as what is most 
important to you… 
because I would say that 
impulsively spending my 
grocery money or being 
un motivated to play 
with my daughter (which 
she talks about earlier) 
are more significant 
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daughter to be raised in 
one, I want my 
stepdaughter to be raised in 
one and I want my next 
child to be raised in 
one….” 
 
 
Value:  
Support 
Presence 
“PI: So during that time 
who would you say was 
your most supportive 
person  
N: My Godmother was, she 
still is to this day  
PI: What is her name 
N: Tanya. She has been 
very supportive. She 
supports to the point where 
she considers me a 
daughter to her and [her 
daughter] as a 
granddaughter to her. The 
good thing about her is she 
went with me when to find 
out what I was having and 
she is going to go with me 
when I find out what I am 
having with this one so it 
has been a big help. “ Pg. 6 
Its interesting 
how she views 
support… the fact that 
she was present for the 
gender sonogram was 
really significant to her.  
It would be 
interesting to look at 
what support means at 
different socioeconomic 
levels… 
Value:  
Therapist 
PI: Are you seeing a 
therapist? 
N: Yes 
PI: How often do you see 
her? 
N: I see her every Thursday  
PI: Ok so once a week 
N: Yeah 
PI: Has that been helpful to 
you 
N: Yes very helpful 
PI: Does she help you do a 
better job at taking a hold 
of your thoughts and 
redirecting….. 
N: We were just talking 
about how I had been 
She talks 
somewhere else about 
how important the 
mere talking part is 
important to her. 
 
You see how 
the therapist helped 
Naomi in some of the 
day to day activities 
Validation/affirm
ation  was also important 
to Caroline too! 
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trying to straighten up my 
house, like I didn’t realize 
last week I had a pile of 
clothes that had to be done, 
I finally got my clothes 
done, got my vacuuming 
done, got my dishes done 
and I was so happy. I was 
so happy to have my house 
looking like it should 
be..”Pg.9 
 
Value: 
Family Support 
“N: My parents are very 
supportive with what is 
going on and very 
supportive of this 
pregnancy, my godmother 
is very supportive of me 
when it comes to all of this 
and it actually makes it 
easier...” Pg. 9 
This support 
makes things easier for 
her  
 
Value: 
Active Lifestyle  
“if I am not doing anything, 
I might take her to the park 
like I told her today if it is 
still nice out when we get 
home we will go to the 
store and than we will go to 
the park because I want her 
to start going to the park, I 
want her to be active…”pg. 
10 
 
You see she 
wants good things for 
her daughter and 
herself.  
 
If she follows 
through on this it could 
build her confidence 
about herself and her 
abilities. 
Value: 
Godmother 
 
PI: As far as talking to you 
psychiatric provider or your 
OBGYN and things like 
that, who helped you make 
decisions about how to care 
for your ADHD symptoms? 
Like your mom, dad, you, 
godmother 
N: I am going to say mostly 
me and my godmother and 
my mother because my 
god-sister also had a 
learning disability too.” 
Pg.12 
We see in these 
two instances the 
godmother is important 
because she can relate 
to Naomi, since she has 
a daughter with a 
learning disability, and 
provides for Naomi. I 
would guess that since 
money is tight the fact 
that she buys clothes is 
significant… 
… This made me 
think about support… to 
me support wouldn’t be 
these things… but 
perhaps its because her 
basic needs aren’t met so 
it would be interesting to 
see what type of support 
would be important to 
her 
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“N: They call and check up 
on me. For instance her 
godmother got her pajamas 
for Christmas and for her 
birthday her godmother got 
her an outfit and some 
money and my godmother 
and my godmother’s sister 
had given her some 
money.” Pg.13 
Value: 
Medication 
“..PI: When you are on 
your medication do you 
feel you are less impulsive? 
N: Yes I think much 
clearer.” 
 
“PI: Now we have talked 
about what it looks like 
when feel like your ADHD 
isn’t managed, are there 
specific things that clue 
you off like “oh this is 
totally different, if I was on 
my medication I wouldn’t 
be like this” 
N: Sometimes I feel like 
that. Sometimes I feel like 
if I was on my medication 
and I was taking it every 
day I want to be more 
active, be more out of the 
house because I am in the 
house all the time. I used to 
have a structure everyday 
with [my daughter] or we 
would go out every day and 
just take a walk and come 
back to the house, and I 
feel like I don’t even want 
to do that anymore.”Pg. 14 
We see here 
that the medication is a 
huge resource for her… 
and that taking the 
medication away does 
impact her ability to 
manage her impulses 
the most significantly 
 
Value:  
Easier 
Healthcare 
Access 
PI: You talked about your 
OB person with your first 
pregnancy wasn’t as 
supportive as the person 
you have now… 
 Having to see 
two different doctors 
seemed like a difficult 
transition for her 
during her first 
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N: Well the differences that 
I don’t like the fact how 
Duke couldn’t deal with 
my high risk so they had to 
send me to Duke prenatal 
care unlike the place I am 
at now, even though I am 
high risk they can still treat 
me even though I am high 
risk and I like that. Also the 
fact that the doctor that I 
have now she is both of our 
doctors me and [my 
daughter] so that helps” Pg. 
16 
 
pregnancy. So now, 
this pregnancy she has 
a different experience, 
a more positive 
experience. 
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APPENDIX 10: Caroline CODE Application and Summary 
 
Code- 
Application 
Support for code Explanation Notes: 
 
 
Phase 1-Health 
Threat (Pre 
pregnancy) 
“I guess I knew you just had to go 
cold turkey and it is funny, I mean 
we probably would have tried to get 
pregnant 1-2 years earlier but I was 
in such a crazy place at work and the 
thought of not having my crutch, my 
medication, to make sure that I was 
able to do the things I needed to do 
to support Stephen and I was just not 
an option, I just couldn’t risk that so 
we literally put off having children 
because I was not at a place that I 
could take that risk with work and 
with everything that we had going 
on. ” Pg. 5 
 
PI: When you first found out that 
you were going to have a baby, 
where you ever worried about how 
you would manage your ADHD 
symptoms during your pregnancy 
 
C: Oh yeah 
The risk was 
contemplated well 
before it became an 
actual threat.  A 
threat so large that it 
postponed her having 
a family. 
 
But clearly she 
acknowledges the 
risk to her and her 
wellbeing. 
Interesting 
significance… 
waited to have 
children because 
she didn’t want 
to risk any 
compromise to 
her career.  
Phase 2- Choices PI: Did a provider ever have a 
conversation with you before you 
got pregnant that that might have led 
you to think they would recommend 
for you to stop your medication? 
 
C: Yes. But I mean. I guess. I don’t 
know I feel like it is such an 
awkward conversation. Once you 
become an adult people really stop 
talking to you about it, so there is a 
bit of an embarrassment to it to but I 
Although she says 
this conversation took 
place it doesn’t seem 
like she received any 
information about 
choices and perhaps 
she didn’t probe 
because in her mind 
there weren’t any 
other choices.. this is 
what you need to do 
to have a healthy 
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was kind of embarrassed to just also 
say I would like to get pregnant but I 
am worried how it will effect work 
and all sorts of things if I stop my 
medication. 
Pg. 2 
 
pregnancy.  
Phase 3-Preface 
Construction 
“The healthy pregnancy and having 
a healthy child was number 1 to me. 
SO whatever I had to do I would 
have done it and I tried to do it.” Pg. 
5 
 
“..I mean we probably would have 
tried to get pregnant 1-2 years earlier 
but I was in such a crazy place at 
work and the thought of not having 
my crutch, my medication, to make 
sure that I was able to do the things I 
needed to do to support Stephen and 
it was just not an option, I just 
couldn’t risk that so we literally put 
off having children because I was 
not at a place that I could take that 
risk with work and with everything 
that we had going on..”Pg. 5 
 
The healthy 
pregnancy was what 
heavily influenced 
her decision and her 
workload the timing 
of when she was 
pregnant.  
 
Phase 4- The 
Decision 
 “…and I just think my mentality 
was that I was just going to have to 
hunker through this and just figure 
out how I was going to manage for 
the next 9 months.” Pg. 3 
Here it seems like 
this strategy was 
selected years ago.  
 
Phase 5- 
Consolidation: 
 
“…It sounds silly saying that 
because now that I have her if I have 
to live the rest of my life taking 
anything just to have her I would do 
it. To be a different wife than I 
would I would do whatever I would 
have to do.” Pg.5 
“Well like #1 having a healthy child, 
she is happy, healthy and beautiful 
so that is so important to me. There 
is something to be said that as 
women we go through a lot.” Pg. 8 
Her healthy child was 
confirmation to her 
that she made a good 
choice.  She made a 
deliberate choice to 
d/c her medication so 
that she would have a 
healthy baby… and 
she did. This was the 
outcome she planned 
for  and reinforces the 
fact she made a 
“good” decision. Had 
her baby had defects 
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or she suffered 
greatly then perhaps 
she would have had a 
different perspective 
looking back.  
Need: 
Settled Home 
“We moved Labor Day Weekend 
and then she was born on the 15
th…
 
Yeah. So it was kind of nuts and 
things that I love doing like 
decorating and putting stuff on the 
wall, I just was so overwhelmed that 
the thought of doing something so 
little like “lets put something on this 
wall today” was so overwhelming 
…” 
We see this was 
something she loved 
to do, but couldn't 
because of the baby. 
She only had so many 
resources.. and the 
baby was first.  
Moved 2 weeks 
before had her 
baby. 
Need: Continuity 
of Care 
“My OBGYN never talked to me 
about Adderall or ADD or anything 
like that. I know it is in my record 
because they ask me what are you 
taking birth control and Adderall but 
it never got mentioned or brought up 
to me I just through education I 
know you cant take medication and I 
guess I didn’t really probe them for 
support in that area cause I kind of 
felt like there specialty was in taking 
care of myself and the baby during 
pregnancy and you know just kind 
of like how you go to an ear, nose 
and throat you don’t ask them about 
joint pain or…I just knew that 
wasn’t really where I was going to 
get support and I just think my 
mentality was that I was just going 
to have to hunker through this and 
just figure out how I was going to 
manage for the next 9 months.” 
You get a sense she 
wanted the provider 
to take be the “bridge 
builder” in helping 
her navigate the 
healthcare system. 
She didn’t feel like 
she had the authority 
to bring it up… 
which is probably the 
case for a lot of 
women.   
Although not 
verbalized- 
indicates that she 
would have liked 
for them to care 
for her ADHD 
too… but, she 
didn’t ask.  
 
It makes me 
wonder if she 
would have felt 
more supportive 
having a 
psychiatric 
provider that she 
was continuing 
to see and who 
was 
collaborating 
with her OB 
provider. 
 
And… perhaps 
this conversation 
didn’t come up 
because she saw 
her PCP for her 
ADHD 
medications 
whereas a 
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specialist might 
have had more 
training and 
given different 
support.  
Value: 
Encouraging 
Validation 
PI: What is the one support system 
that if you didn’t have it you didn’t 
think you could have accomplished 
all you did.  
 
C:” For me fortunately my family, 
my mom is number 1. We used to 
talk about it all the time. I would tell 
her if I let this slip today and I 
totally forgot about this and she 
would either tell me about a time 
that that happened to her or she 
would give me something 
relatable….” Pg. 7 
 
“… 
Encouraging 
Validation: This type 
of support and 
affirmation was 
important and helpful 
to her. 
Consistent 
Support or 
Affirming 
Encouragement 
Need: 
Mgmt 
Information 
 
C: I would say that when you are 
pregnant, and I know we have talked 
about this with just each other, but to 
know what other options there are 
out there that are safe for you and 
safe for child, would that be 
medication or whether that would be 
just a recommended that during this 
time why don’t you meet with 
someone bi-weekly or weekly. That 
stuff never really scared me, like “oh 
my gosh if I need to start talking to 
somebody than I must be really 
kooky and no one normal does that” 
So if it would have been 
recommended or suggested then I 
would have totally done that. I guess 
it is being in Raleigh and its not my 
hometown I never met with anyone 
here and so I never knew how to go 
about finding anyone and I know I 
could google it but I guess it is a 
private thing you do in general and it 
is not like “oh I like your hair. Who 
cuts it” it is just one of those things. 
Mgmt Information: 
 
In this statement she 
talks about a two 
fold… 1) how if 
someone (sounds like 
she would have taken 
a friends word) had 
suggested other 
ADHD mgmt. 
options, like talking 
to someone it could 
have helped her face 
the challenges 
differently 
 
2) but just knowing 
there are other 
options doesn’t 
connect you to them. 
Therefore we also 
need providers to list 
out the available 
resources as Caroline 
clearly states this 
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If it is not your medical provider, I 
mean they give you 90 million 
pamphlets anyway, that would have 
been one that would have really 
helpful and even feel comfortable 
talking to them about it which I 
talked to them about, I mean they 
would block 45 min for my 15 min 
appointment because I asked them 
questions all the time, but if they had 
just suggested it or said here is some 
information and if you are interested 
let us know or call this number than 
I would have totally taken them up 
on that. 
 
 
resource is personal 
it’s not like asking 
someone where they 
get their hair cut.   
 
Feeling: 
Pregnancy 
Discomfort  
“…Part of it too was probably a 
personality change, I was just over 
being pregnant and over having 
cankles and hands that were so 
swollen they were bigger than my 
husbands, you know there were so 
many other factors that could have 
contributed to that like I am in a job 
that has so many spinning plates at 
one time..” Pg. 6 
Pregnancy 
Discomfort: I think 
its important to 
remember that 
ADHD women 
experience all the 
“normal” emotions or 
discomforts of 
pregnancy… on top 
of the challenge of 
managing their 
ADHD. 
Normal 
Pregnancy 
Symptoms= 
added discomfort 
Feeling: 
Good 
“I am back on my medication now 
and I feel like I am back to me again 
and it feels really good.” 
Good: This goes back 
to her identity and 
this statement of 
relief when she is 
back on her 
medication and 
“reacquainted” with 
her old self.  
Identity perhaps 
in her work 
performance 
Feeling: 
Inept 
“PI: Do you feel like it impacted 
your self-confidence? 
 
C: Oh yes.  
 
PI: Because you were unable to 
perform the way you knew that you 
could 
 
Inept:  I almost get 
the sense that she 
feels disabled… she 
knows she can 
perform better but in 
this time period she 
can’t and that is a 
different mentality 
then saying “yeah, I 
Competitive 
work 
environment 
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C: Oh absolutely. All my peers, 
everybody there is like no, this is the 
first group of individuals that I am 
working with all the A+ students of 
the class. There are no C level 
workers where you feel like if you 
competed against them you know I 
am going to win because they don’t 
care what they are doing….” Pg. 6 
didn’t perform like I 
could have but, this is 
only temporary I 
know that I won’t 
always been 
struggling.  
Value: 
Healthy 
Pregnancy 
C: The healthy pregnancy and 
having a healthy child was number 1 
to me. SO whatever I had to do I 
would have done it and I tried to do 
it. Pg 5 
Healthy Pregnancy: 
This statement clearly 
indicates that a 
healthy pregnancy 
was her top priority 
and therefore you see 
her decisions about 
d/c her medication 
are related to this.  
 
Value:  
Providing  for 
my family 
“..I mean we probably would have 
tried to get pregnant 1-2 years earlier 
but I was in such a crazy place at 
work and the thought of not having 
my crutch, my medication, to make 
sure that I was able to do the things I 
needed to do to support Stephen and 
it was just not an option, I just 
couldn’t risk that so we literally put 
off having children because I was 
not at a place that I could take that 
risk with work and with everything 
that we had going on..”Pg. 5 
Providing  for my 
family: She has 
identified herself as 
the provider in the 
family and this 
carries a lot of weight 
in her decisions about 
managing her ADHD  
 
Value:  Work 
Accolades 
“…, I am back on my medication 
now and I feel like I am back to me 
again and it feels really good… at 
least during work and stuff like that 
I am able to hunker down and also 
become the performer I enjoy being 
and I have been recognized for 
being….” Pg. 6 
Work Accolades: 
Here we see she 
identifies her work 
accolades as an 
important part of who 
she is.  
 
Pre-Pregnancy: 
Work 
Responsibilities:  
“…its crazy because it is the perfect 
blend of what my weaknesses are 
which is multitasking and making 
sure that I complete projects, but it 
also keeps me energized and excited 
because it is never just a desk job. 
There are constantly new things 
Work 
Responsibilities: You 
can see that this is a 
factor that heavily 
influences her- she 
talks about putting 
off her family 
D: Because of 
the lack of 
sustained 
attention- maybe 
drawn to jobs 
that require 
multi-tasking to 
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going on and I can control the 
newness of what I do…”Pg. 6 
 
“I mean we probably would have 
tried to get pregnant 1-2 years earlier 
but I was in such a crazy place at 
work and the thought of not having 
my crutch, my medication, to make 
sure that I was able to do the things I 
needed to do to support Stephen and 
it was just not an option, I just 
couldn’t risk that so we literally put 
off having children because I was 
not at a place that I could take that 
risk with work and with everything 
that we had going on. “ Pg.6 
because of work and 
alludes to the fact that 
she is possibly the 
breadwinner “ I 
needed to support 
Stephen”.   You can 
see why this heavily 
influenced her 
decision 
keep attention, 
however their 
not the nature of 
the disorder 
ADHD people 
don’t possess the 
natural traits 
needed to be 
successful. 
Medication helps 
bridge these 
deficits for 
ADHD people 
but without meds 
these deficits 
surface.   
Value:  Normal 
Routine 
“…Honestly the first week of taking 
it after being pregnant I was very 
pleased, I was able to get out of the 
house, organizing myself in lists, 
and checking things off. For me it is 
the little things that make a big deal 
that I struggle with and so that was 
really helpful…”pg. 7 
Normal Routine:  
This is motivating for 
her in the sense that 
she feels “normal” 
returning to the 
coping skills she has 
already established 
while she is on her 
medication. The key 
from this statement 
maybe that we need 
to support women 
with ADHD during 
pregnancy by helping 
them learn a new set 
of coping skills when 
they aren’t 
medicated… because 
from her experience 
her old “tricks” didn't 
necessarily work like 
they did when she 
was on meds.  
 
Value:  
Overcoming a 
Challenge 
…” Everything that you physically 
and mentally go through and to look 
back now and see where I am now 
and how much I have gone through 
and how much I was able to do on 
my own but also through the support 
of others, that is pretty significant 
Overcoming a 
Challenge: 
This seemed to be a 
confidence boost for 
her given the toll this 
experience had left 
on her self-esteem. 
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and empowering for me.” Pg. 8 This perspective 
could impact her 
decision next time 
she decides to get 
pregnant.. “I’ve done 
it before successfully 
and I can do it again” 
Value: Support “But my mom …and family where 
all so supportive and they would 
constantly come in and taking 
breaks and cooking dinner, cleaning 
the house, unpacking boxes and 
things like that. That was really very 
comforting. You have to have a 
support system I feel like; at least 
for me personally that is what helped 
me stay sane.” Pg. 4 
 
Support: In an earlier 
comment she talks 
about how her family 
and husband stepped 
up in ways she didn’t 
expect. They eased 
the burden for her 
and kept her “sane”. 
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APPENDIX 11: Theme Confirmation 
 
Theme: Lack of Prenatal Patient-centered  Care 
Source Quote Notes  
Caroline  “…but it never got mentioned 
or brought up to me …and I 
guess I didn’t really probe 
them for support in that area 
cause I kind of felt like there 
specialty was in taking care of 
myself and the baby during 
pregnancy …I just knew that 
wasn’t really where I was 
going to get support …” 
 
“[To] know what other options 
there are out there that are safe 
for you and safe for child, 
would that be medication or 
whether that would be just a 
recommended that during this 
time why don’t you meet with 
someone bi-weekly or 
weekly.” 
 
“…I think that would have 
probably been a benefit being 
pregnant and even after 
pregnancy with breast-feeding 
and everything like that.” 
 
 
OB/GYN continuity of care 
Naomi No, they made me go off of 
it…the doctor said you can’t 
be on ADD medicine while 
you are pregnant”.   
 
Lack of conversation about 
options 
Naomi “… I don’t like the fact 
how…[they]... couldn’t deal 
with my high risk so they had 
to send me to another prenatal 
First pregnancy had to see two 
different doctors for her 
prenatal care… but now goes 
one place. She emphasized 
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care place unlike the place I 
am at now, even though I am 
high risk they can still treat me 
even though I am high risk 
and I like that”.   
several times how much she 
valued this 
Naomi “[To know] what they could 
have put me on, even if it 
wasn’t that strong, but at least 
something to help control my 
ADHD and my impulses while 
I am pregnant.”  
 
PI: Would have been helpful 
for someone to have actually 
talked to her about some 
options, she responded 
“Exactly”.  
 
Naomi is sharing that she 
needs some different support. 
In this quote, she is talking 
about medications, but I think 
it is important to highlight that 
she is verbalizing needing 
more from her provider.  
Naomi PI: During this pregnancy, 
now you know more, where 
you as worried as how you 
would manage your ADHD 
N: I was so stressed I didn’t 
even know, and now it is like I 
feel like managing it, one 
thing I hate is the fact that 
sometimes I feel like I can’t 
focus like there are a lot of 
times I will get my …Usually 
my impulses would make me 
spend it automatically without 
even thinking about it. 
Another thing with dealing 
with her (baby) my focus too, 
is in the beginning, I am good 
with hygiene with me but not 
with her but I am trying to do 
better with that.” 
We see this reflected again in 
this  paragraph about 
significance 
Theme: Primary Support 
Source Quote  Notes 
Caroline (referring to her 
mother) 
I would tell her …I totally 
forgot about this and she 
would either tell me about a 
time that that happened to her 
or she would give me 
We see in this quote 
Caroline’s relationship with 
her mother and the support she 
receives from her that is so 
important during her 
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something relatable. I 
remember she would 
cheerlead me “you are going 
to have this baby and you are 
going to be so happy when 
you have her”…She would 
always cheer me on “don’t 
worry you have one more 
month.”   
pregnancy.  
Caroline “But my mom …and family 
where all so supportive and 
they would constantly come in 
and taking breaks and cooking 
dinner, cleaning the house, 
unpacking boxes and things 
like that. That was really very 
comforting. You have to have 
a support system I feel like; at 
least for me personally that is 
what helped me stay sane.” 
 
 
Naomi “My Godmother was, she still 
is to this day… She has been 
very supportive. She supports 
to the point where she 
considers me a daughter to her 
…. The good thing about her 
is she went with me when to 
find out what I was having and 
she is going to go with me 
when I find out what I am 
having with this one so it has 
been a big help.”   
 
Naomi “…my godmother and my 
godmother’s sister had given 
her (her daughter) some 
money.”  
 
Theme: Mothering 
Source Quote Notes 
Caroline “The healthy pregnancy and 
having a healthy child was 
number 1 to me. So whatever I 
had to do I would have done it 
and I tried to do it.”  
 
Healthy pregnancy and child 
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Naomi “I am trying to get myself to 
go every Sunday but 
something always stops me 
and I don’t like that because I 
want to raise my kids in the 
religion …I need to start going 
to one because I want my 
daughter to be raised in one, I 
want my stepdaughter to be 
raised in one and I want my 
next child to be raised in 
one….”  
 
“reaching out to God for help. 
That is what I can say really 
helped me out a whole lot. 
Like I said, I like coming to 
therapy because I can talk 
about what is going on and I 
like going to church because I 
feel like I can talk about what 
is going on to.”  
Spiritual growth and 
development:  this is very 
important for Naomi’s growth 
and feeling grounded that she 
wants her children to have the 
same foundation. 
Naomi reiterates this theme when 
sharing some of the behaviors 
she would like to change, for 
example “if I am not doing 
anything, I might take her to 
the park like I told her today if 
it is still nice out when we get 
home we will go to the store 
and then we will go to the 
park because I want her to 
start going to the park, I want 
her to be active…” 
 
Wants children to be more 
active than her 
Theme: Provider as the Barrier to Information 
Source Quote Notes 
Naomi “PI: Did your provider ever 
talk about any treatment 
options other than medicine? 
N: The only medicine they 
gave me mY was prenatal pills 
that was it that was all they 
gave me. ”  
 
 Full trust in provider 
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Naomi “No, they made me go off of 
it….the doctor said you can’t 
be on ADD medicine while 
you are pregnant”  
Takes this conversation at face 
value 
Caroline My OBGYN never talked to 
me about Adderall or ADD or 
anything like that. I know it is 
in my record because they ask 
me what are you taking birth 
control and Adderall but it 
never got mentioned or 
brought up to me I just 
through education I know you 
can’t take medication and I 
guess I didn’t really probe 
them for support in that area 
cause I kind of felt like there 
specialty was in taking care of 
myself and the baby during 
pregnancy and you know just 
kind of like how you go to an 
ear, nose and throat you don’t 
ask them about joint pain 
or…I just knew that wasn’t 
really where I was going to get 
support and I just think my 
mentality was that I was just 
going to have to hunker 
through this and just figure out 
how I was going to manage 
for the next 9 months.” 
Wants the provider to bring 
this up… but doesn’t feel like 
she has the authority 
Theme: Unmanaged ADHD Symptoms 
Source Quote Notes 
Caroline C: I would say that when you 
are pregnant…, to know what 
other options there are out 
there that are safe for you and 
safe for child, would that be 
medication or whether that 
would be just a recommended 
that during this time why 
don’t you meet with someone 
bi-weekly or weekly. That 
stuff never really scared me, 
like “oh my gosh if I need to 
start talking to somebody then 
In this statement she talks 
about a two fold… 1) how if 
someone (sounds like she 
would have taken a friends 
word) had suggested other 
ADHD mgmt. options, like 
talking to someone it could 
have helped her face the 
challenges differently 
 
2) but just knowing there are 
other options doesn’t connect 
you to them. Therefore we 
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I must be really kooky and no 
one normal does that”. So if it 
would have been 
recommended or suggested 
then I would have totally done 
that. I guess it is being in [this 
town] and its not my 
hometown I never met with 
anyone here and so I never 
knew how to go about finding 
anyone and I know I could 
google it but I guess it is a 
private thing you do in general 
and it is not like “Oh I like 
your hair, who cuts it” it is just 
one of those things. If it is not 
your medical provider, I mean 
they give you 90 million 
pamphlets anyway, that would 
have been one that would have 
really helpful and even feel 
comfortable talking to them 
about it which I talked to them 
about, I mean they would 
block 45 min for my 15 min 
appointment because I asked 
them questions all the time, 
but if they had just suggested 
it or said here is some 
information and if you are 
interested let us know or call 
this number than I would have 
totally taken them up on that. 
 
 
also need providers to list out 
the available resources as 
Caroline clearly states this 
resource is personal it’s not 
like asking someone where 
they get their haircut.   
 
Naomi PI: During this pregnancy, 
now you know more, where 
you as worried as how you 
would manage your ADHD 
N: I was so stressed I didn’t 
even know, and now it is like I 
feel like managing it, one 
thing I hate is the fact that 
sometimes I feel like I can’t 
focus like there are a lot of 
times I will get my impulses 
This is one of the few times 
where she uses the word 
“stressed” … I think. Never 
the less this is a daily struggle.  
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but I was proud of myself 
yesterday because I got money 
yesterday and I haven’t spend 
it yet, I was proud because I 
said I wasn’t going to spend it 
today I was going to spend it 
tomorrow, I am going to get 
what I really want to get. 
Usually my impulses would 
make me spend it 
automatically without even 
thinking about it. Another 
thing with dealing with her my 
focus too, is in the beginning, 
I am good with hygiene with 
me but not with her but I am 
trying to do better with that..” 
Naomi “..PI: When you are on your 
medication do you feel you 
are less impulsive? 
N: Yes I think much clearer.” 
 
“PI: Now we have talked 
about what it looks like when 
feel like your ADHD isn’t 
managed, are there specific 
things that clue you off like 
“oh this is totally different, if I 
was on my medication I 
wouldn’t be like this” 
N: Sometimes I feel like that. 
Sometimes I feel like if I was 
on my medication and I was 
taking it everyday I want to be 
more active, be more out of 
the house because I am in the 
house all the time. I used to 
have a structure everyday with 
[her daughter] or we would go 
out everyday and just take a 
walk and come back to the 
house, and I feel like I don’t 
even want to do that 
anymore.” 
Naomi articulates how helpful 
her medication was for her but 
hasn’t really articulated this to 
her provider.  
Caroline “I am back on my medication 
now and I feel like I am back 
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to me again and it feels really 
good.” 
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